Indian FMCG Sector: The Volume Comeback — Why FY27 Will Reward Pricing Power and Rural Recovery

Snapshot Date: 14 June 2026 | Sector universe: 10 listed companies (Nifty FMCG constituents) | Aggregate market cap: ~₹17.7 lakh crore | Read time: ~70 minutes

1. Sector Overview & Economic Context

The Indian Fast Moving Consumer Goods (FMCG) sector is the second-largest consumption pocket of the Indian equity market and the most defensive cash-flow engine in the Nifty 50 universe. As of 14 June 2026, the Nifty FMCG index houses 10 listed companies with an aggregate market capitalisation of approximately ₹17.7 lakh crore (~US$210 billion). The sector is dominated by the Hindustan Unilever–ITC–Nestle India triumvirate, which together account for ~63% of the index weight by free-float market capitalisation, with the remaining seven names — Britannia, Dabur, Marico, Godrej Consumer Products, Colgate-Palmolive (India), Tata Consumer Products, and Emami — rounding out the top 10. The Nifty FMCG index closed at ~54,820 on 13 June 2026, having spent the last twenty-four months in a narrow range of 48,000–58,000, a behaviour that has frustrated momentum investors and rewarded the dividend-yield crowd. The single most important narrative reshaping the sector in FY26 and setting up FY27 is what we are calling the volume comeback — a return to mid-single-digit underlying volume growth across urban and rural India, anchored in stabilising real wages, a normal monsoon forecast, the maturing benefits of the September 2025 GST 2.0 rate rationalisation, and the first clear signs that rural consumption is finally catching up with its urban counterpart after a four-year lag.

The FMCG sector is structurally distinct from every other consumption pocket on the Nifty. It is asset-light, cash-generative, distribution-intensive, and brand-compounding. The top 10 names have an aggregate return on capital employed (ROCE) of ~38% (screener.in consolidated, FY26), an aggregate free cash flow conversion of ~94% of net profit, an aggregate debt-to-equity of 0.16x, and an aggregate dividend payout ratio of ~78%. These are among the highest-quality operating metrics in the entire Indian listed universe. The trade-off, of course, is growth: the same names grew consolidated revenue at a 5-year CAGR of 8.4% and net profit at a 5-year CAGR of 7.9%, materially below the broader Nifty 50's 13% revenue CAGR and 17% profit CAGR. FMCG is the slow-grind compounder's paradise and the growth investor's desert. The question for FY27 is whether the volume comeback will close that growth gap enough to re-rate the multiples — and our analytical answer, detailed over 11 sections, is a qualified yes for the most pricing-power-endowed names and a flat-to-down call for the structurally challenged ones.

The economic backdrop is decisive. India's nominal GDP crossed ₹330 lakh crore (US$3.95 trillion) in FY26 per MoSPI's January 2026 release, with the broader services sector accounting for 53.6% of GVA and the manufacturing sector for 17.2%. The critical sub-component is Private Final Consumption Expenditure (PFCE), which has reaccelerated from a tepid 3.5% YoY in FY24 to 6.1% in FY25 and an estimated 6.8% YoY in 9M FY26 based on National Accounts Statistics. Within PFCE, the share spent on FMCG (food, beverages, personal care, household care) is estimated at ~28% per a March 2026 CRISIL Ratings report on Indian consumption patterns, up modestly from 26% pre-COVID as the services share has compressed. The household savings rate, which cratered to 18.4% in FY23, has recovered to ~20.1% in FY25 and stabilised, per RBI's household finance survey published in March 2026. The combination of stabilising savings, recovering real wages (nominal wage growth in agriculture at 6.8% YoY in FY26 vs. 4.2% in FY24), and a normal southwest monsoon forecast (IMD's first stage forecast of 96% of LPA with a model error of ±5%) sets up the rural recovery thesis.

The sector is also a beneficiary of the GST 2.0 regime that took effect on 22 September 2025. The rate rationalisation moved most daily-use FMCG products — soaps, shampoos, toothpastes, packaged foods, biscuits, dairy — from the 18% slab to the new 5% merit slab, while a small number of "sin-good" categories (aerated drinks, tobacco, luxury) remained in the 28% slab. The transmission has been uneven: large branded players took a 50–80% pass-through, mid-sized players took 100% pass-through, and unbranded regional players effectively took prices down by 13 percentage points. The result has been a volume acceleration in H2 FY26 for the listed players, particularly in low-unit-price SKUs in soaps, detergents, biscuits, and shampoos. HUL management, on its Q3 FY26 call, noted that volume growth re-accelerated from 1% in H1 FY26 to ~3% in Q3 FY26 and ~5% in Q4 FY26, with the management guidance for FY27 being a return to "high single-digit underlying volume growth" — a phrase that, if delivered, would be the strongest volume print in four years. ITC, similarly, reported that its FMCG-Others segment volume growth crossed 6% YoY in Q4 FY26, with foods, personal care, and stationery all delivering positive volume growth. Marico's parachute coconut oil volumes were up 4% YoY in Q4 FY26 after seven consecutive quarters of decline. The volume signal is real.

The sector's 29 other listed names outside the Nifty FMCG index — including Varun Beverages, United Breweries, United Spirits, United Foods, Mrs Bectors, Bikaji, Patanjali Foods, AWL Agri, and a long tail of small-cap food and personal care operators — trade on different multiple and growth curves and are not the focus of this report. The Nifty FMCG index universe is a closed list of 10 names; the broader BSE FMCG index has 38 constituents but the Nifty FMCG captures ~92% of the listed FMCG market cap by free-float, and that is the appropriate investible universe for institutional asset allocators. We work exclusively from the Nifty FMCG list.

Source: NSE, BSE, company filings, screener.in consolidated, NiftyBrief compilation as on 13 June 2026. FY26 = year ending March 2026 for all constituents.

1.1 Why this matters now: the FY27 setup

Three forces converge to make FY27 a make-or-break year for the sector. First, the rural-urban convergence. The NCAER Rural Consumer Confidence Index for Q4 FY26 stood at 62.4 (vs. 58.1 a year ago), its highest level since Q2 FY22, while the urban index stood at 68.9. The gap has narrowed from 14 points in Q4 FY24 to 6.5 points in Q4 FY26. Rural FMCG sales growth, per a NielsenIQ India report published in March 2026, was 8.2% YoY in CY25 vs. 6.4% in CY24, while urban was 6.1% in CY25 vs. 7.8% in CY24. The first time in 5 years that rural growth has materially outpaced urban. This is the single most important demand variable for the listed FMCG universe, given that rural contributes 35–40% of revenue for HUL, ~30% for Dabur, ~25% for Marico, and ~33% for Britannia.

Second, the input cost cycle has decisively turned favourable. The composite FMCG raw material basket — a weighted index of palm oil, crude (linked to packaging and petrochemicals), copra, sugar, milk solids, wheat, barley, mentha oil, and aluminium — was down ~7% YoY on average in FY26 and is expected to be down another 3-5% in FY27 based on April-May 2026 spot prices and futures curves. Crude at $68-72/bbl (Brent), palm oil at MYR 3,850-4,100/MT, copra at ₹11,200-12,000/quintal, mentha oil at ₹1,150-1,250/kg — every major input is at a 2-4 year low. The gross margin tailwind for FY27 is real and quantifiable: ~50-120 bps of gross margin expansion for the universe, depending on category mix.

Third, the GST 2.0 anniversary base effect. The September 2025 GST rate cuts will anniversary in H2 FY27, and the volume growth comparison will be the cleanest in five years (no festive base distortion, no commodity spike, no election-related stock-out). Q2 FY27 (Jul-Sep 2026) will be the first full quarter of a "low-GST, low-raw-material, normal-monsoon" combination — that is the quarter in which the sector should deliver the highest revenue growth in 6 quarters.

1.2 The 70-year arc of Indian FMCG

The Indian FMCG sector has gone through three distinct capital-allocation eras. Era 1 (1950-1991): the licence-quota era, in which the sector was dominated by a handful of family-owned conglomerates (Godrej, Tata, Birla, Modi) operating in protected markets with limited brand investment. The combined listed market cap of the FMCG sector at the start of liberalisation (1991) was less than ₹5,000 crore. Era 2 (1991-2015): the liberalisation-multinational era, in which HUL, Nestle, Procter & Gamble, Colgate, Reckitt, and a clutch of Indian challengers (Dabur, Marico, Emami, Britannia) battled for share in a market that grew from $10 billion in 1991 to $50 billion by 2015. The combined listed FMCG market cap crossed ₹5 lakh crore by 2015 and ₹10 lakh crore by 2020. Era 3 (2015-present): the consolidation-platform era, in which a handful of platform-scale incumbents (HUL, ITC, Nestle, Britannia) have consolidated category leadership, smaller players have been acquired (HUL's Indulekha, Lakme, Aditya Birla Group's merger with Grasim's consumer play, ITC's acquisition of Sunrise Foods, Britannia's stake in Modern Foods), and the digital-first D2C brands (mamaearth, WOW Skin Science, Sugar Cosmetics, Boat) have carved out 4-7% category share in personal care but have struggled to scale profitably.

The combined listed FMCG market cap crossed ₹17 lakh crore in mid-2025 for the first time, and currently stands at ~₹17.7 lakh crore. The sector's share of the Nifty 50 free-float market cap has compressed from ~12% in 2015 to ~6.5% in 2026 as the broader market has re-rated faster — a trend that the FY27 setup could begin to reverse if the volume comeback delivers.

1.3 TAM, sub-verticals, and the size of the prize

The Indian FMCG TAM is estimated at US$110-125 billion in CY25 (per a McKinsey India consumer report from March 2026 and a Bain & Company India report from February 2026), growing at 10-12% in nominal terms and projected to cross US$200 billion by CY30. The TAM is split across four broad sub-verticals: Foods & Beverages (~45% of TAM), Personal Care (~22%), Home Care (~18%), and Tobacco & Cigarettes (~15%). The Nifty FMCG index universe has differentiated exposure across these sub-verticals, with the foods-and-beverages bucket being the largest aggregate revenue contributor at ~46%, followed by personal care at ~24%, home care at ~17%, cigarettes at ~12%, and other (paperboards, packaging, agri) at ~1% (the ITC mix adjustment).

Source: McKinsey India Consumer Report (Mar-2026), Bain India Consumer Report (Feb-2026), company annual reports, NiftyBrief compilation.

The sub-vertical disaggregation matters because pricing power, margin profile, and growth trajectory are very different across the four buckets. Foods & Beverages has the highest TAM growth (13% CAGR) but the lowest margin (mid-teens EBITDA margin for most players) and the highest input cost volatility. Personal Care has the second-highest growth (11.3%) with mid-20s EBITDA margins for the leaders. Home Care is mature (11.8% CAGR) with 18-22% EBITDA margins. Tobacco is a low-growth, high-cash, single-player category dominated by ITC (5% CAGR but 40%+ EBITDA margins). The investment implications of these four trajectories are starkly different and are mapped in detail in Section 5 and Section 11.

1.4 The defining FY26 numbers in one table

Source: Screener.in consolidated, FY26 = year ending March 2026. ITC FY26 PAT declined YoY due to the one-time gain on ITC Hotels demerger in FY25 (₹14,011 cr exceptional) being absent in FY26. The headline numbers strip the exceptional and reflect the underlying business trajectory.

2. Five Forces & Regulatory Framework

The Indian FMCG sector sits at an unusual intersection of high competitive intensity, low customer switching costs in some categories and very high in others, meaningful regulatory permissiveness, and rising capital intensity in distribution and brand investment. A rigorous Five Forces analysis must be anchored in the post-GST 2.0, post-pandemic, post-quick-commerce-launch reality, not the textbook framework of the 2005-2015 era. We re-do the Porter analysis for FY27 with current data.

2.1 Threat of new entrants — Moderate, falling

The threat of new entrants in Indian FMCG is moderate and falling. The principal barrier to entry is the distribution scale required to reach India's 12-13 million retail outlets, the working capital intensity of an FMCG operating model (typically 60-90 days of receivables plus 45-60 days of inventory minus 30-45 days of payables = ~60-90 day net working capital cycle), and the brand-building capital required to win shelf space and consumer mindshare. The D2C disruptors of 2018-2023 — mamaearth (Honasa Consumer, listed 2024), WOW Skin Science, Sugar Cosmetics, MCaffeine, Plix, mCaffeine, Juicy Chemistry, and a long tail — have demonstrated that brand-building capital is meaningful but not insurmountable. The combined D2C FMCG market cap is currently ~₹20,000 crore (Honasa, Honasa's market cap is ~₹9,000 cr, plus a long tail of small-caps), of which Honasa Consumer (mamaearth) is the only listed D2C at scale. Honasa's revenue of ~₹2,200 crore in FY25 is less than 4% of HUL's personal care revenue. The D2C threat is real but at the margin; the platform-scale incumbents (HUL, ITC, Nestle, Marico, Godrej CP, Dabur, Tata Consumer) have the distribution moats, the marketing efficiency, and the balance sheet to absorb the disruption.

The biggest new-entrant threat in FY27 comes from two directions. First, the China-plus-one Indian consumer brands — the new wave of Indian brands (Plix, Wellbeing Nutrition, Bold Care, Perfora, Pilgrim, Be Bodywise, Dr. Vaidya's) raising venture capital and scaling aggressively. The combined addressable market for these brands is concentrated in hair care, skin care, sexual wellness, men's grooming, and functional nutrition, with combined revenue exceeding ₹6,000 crore in FY25 (per a RedSeer report from December 2025) and growing at 35-50% YoY. Second, the platform expansion of quick commerce and modern retail (DMart, Reliance Retail, Avenue Supermarts, Tata Neu, JioMart) which compresses the listing-to-shelf cycle for new brands from 6-12 months to 6-12 weeks and gives smaller brands a distribution channel that does not require building a sales force. Both of these are net positive for the listed incumbents, because they expand the total category market and bring more consumers into the branded-FMCG orbit.

2.2 Bargaining power of suppliers — Low to Moderate, falling

The bargaining power of suppliers in Indian FMCG is low to moderate and structurally falling. The inputs are commoditised agricultural commodities and petrochemicals — palm oil (imported, ~70% from Indonesia/Malaysia), crude (linked to packaging and surfactants), copra (domestic), sugar, wheat, milk solids, mentha oil (mainly from Uttar Pradesh), aluminium, glass, and HDPE/LDPE. None of the suppliers individually has pricing power that can be extracted from the FMCG majors, because the commodities trade on global exchanges (palm oil on BMD, crude on NYMEX/ICE, mentha oil on MCX) and there is ample supply. The two exceptions are mentha oil (a near-monopoly supply region in UP's Barabanki-Lucknow belt, with weather-driven price spikes) and copra (concentrated in Tamil Nadu, Kerala, Karnataka). Marico's coconut oil (parachute brand) is the largest single buyer of copra in India, which gives it some pricing power, but the converse is also true — bad copra crops can compress parachute margins, as happened in FY23 and FY24.

The FY27 input cost outlook is decisively favourable, as discussed in Section 1.1. Crude at $68-72/bbl (vs. $82-88 average in FY25), palm oil at MYR 3,850-4,100/MT (vs. MYR 4,200-4,600 in FY25), copra at ₹11,200-12,000/quintal (vs. ₹12,500-14,000 in FY25), mentha oil at ₹1,150-1,250/kg (vs. ₹1,400-1,800 in FY25), sugar at ₹36-38/kg (vs. ₹38-42 in FY25), milk solids at ₹290-320/kg SMP (vs. ₹310-340 in FY25). Every major input is at a 2-4 year low. The gross margin tailwind for the universe is 50-120 bps in FY27, with the larger beneficiaries being HUL (home care, personal care), Marico (coconut oil, saffola), Dabur (chyawanprash, hair oils), and Emami (mentha-based products).

2.3 Bargaining power of buyers — Moderate and rising

The bargaining power of buyers (consumers and retailers) in Indian FMCG is moderate and rising, driven by the maturation of modern retail, the rise of e-commerce and quick commerce, and the increasing price transparency enabled by digital platforms. The end-consumer in most FMCG categories has very low individual bargaining power (no single consumer can negotiate price with HUL or Nestle), but aggregate consumer behaviour — driven by choice, switching, and willingness to pay a premium — has been a powerful force in shaping the sector's evolution. The modern trade channel (supermarkets, hypermarkets, organised retail) currently accounts for ~12% of FMCG sales (per a NielsenIQ India report from March 2026) but is growing at 18-20% YoY vs. 6-8% YoY for traditional trade, which means its share will cross 20% by FY30. Modern trade players (DMart, Reliance Retail, Spencer's, Star Bazaar, More, D-Mart Ready) have meaningful bargaining power on listing fees, slotting allowances, and exclusive brand programmes. Quick commerce (Blinkit, Zepto, Swiggy Instamart, BBnow, BigBasket) has emerged as a new high-bargaining-power buyer in FY25-FY26, with platform commissions of 18-25% of GMV on FMCG sales and aggressive negotiating stances.

The rural consumer, which represents ~35-40% of FMCG demand, has low individual bargaining power but very high aggregate responsiveness to pricing and promotional intensity. The post-GST 2.0 volume data shows that the rural consumer is willing to trade up to branded FMCG when the price-point gap to unbranded narrows — a structurally favourable dynamic for the listed incumbents.

2.4 Threat of substitutes — High and rising in Foods, Moderate in Personal Care

The threat of substitutes in Indian FMCG is high and rising in foods, moderate in personal care and home care. The foods sub-vertical is the most exposed: a ₹100 packet of branded biscuits faces competition from loose biscuits, local bakeries, unbranded savouries, and increasingly from cloud kitchens, ready-to-eat meals, protein supplements, and functional foods. The organised fresh foods and direct-from-farm delivery (DeHaat, Ninjacart, Otipy) is also a substitute for branded packaged foods in fresh categories (dairy, fruits, vegetables, meat). The direct-to-consumer fresh food delivery market is estimated at ₹12,000 crore in FY25 and growing at 35% YoY (per a RedSeer report). This is a 1% substitute risk for the listed FMCG foods players today but rising.

The personal care sub-vertical faces substitute pressure from D2C brands, ayurvedic/natural-positioned brands (Dabur's core positioning, Patanjali, Himalaya, Lotus Herbals), and professional salon services. The at-home salon services (Urban Company, Yes Madam, Bodycraft) are a modest but real substitute for premium personal care SKUs, particularly in hair care, skin care, and grooming. The home care sub-vertical is the least exposed to substitutes — laundry, dishwash, floor cleaners, and toilet cleaners are functional purchases with low substitutability beyond unbranded alternatives.

2.5 Competitive rivalry — Intense but consolidating

The competitive rivalry in Indian FMCG is intense but consolidating. The top 10 Nifty FMCG names have an aggregate share of ~52% of the organised FMCG market by value, with the top 3 (HUL, ITC, Nestle) accounting for ~30% of the organised market. The market is structured as oligopoly with local monopolies — each major category has 2-3 dominant players and a long tail of niche brands. The pricing intensity has stepped up since GST 2.0, with the larger players willing to take 2-4% price reductions on key SKUs to defend or gain share. The advertising-and-promotion (A&P) intensity has also risen — aggregate A&P spend for the Nifty FMCG universe in FY26 is estimated at ~₹14,500 crore (per company filings, ~7.4% of net sales), up from ~₹12,800 crore in FY25 (~6.8% of net sales). This is the highest A&P intensity in the sector's history.

2.6 Regulatory framework

The Indian FMCG sector is regulated by 8 principal statutes and 4 main regulators, with the heaviest touchpoints at the central level (FSSAI for food safety, Ministry of Consumer Affairs for legal metrology and weights & measures, DGFT for imports/exports), the state level (excise on alcohol, state VAT on certain inputs, mandi/agriculture marketing), and the municipal level (shop and establishment licensing, fire NOC, FSSAI state licensing, plastic waste management rules). The regulatory load has, on balance, fallen in FY26 with the implementation of GST 2.0 and the consolidation of multiple state-level taxes into the GST regime.

Principal regulatory acts and regulators:

The GST 2.0 rate rationalisation that took effect on 22 September 2025 is the single most consequential regulatory event for the sector in five years. The pre-GST 2.0 structure had 4 main rate slabs (5%, 12%, 18%, 28%) plus a 28%+ cess for sin goods. The new structure has 5 rate slabs (nil, 5%, 12%, 18%, 28%) plus a 40% slab for sin goods. The specific impact for the Nifty FMCG universe is summarised below.

The post-GST 2.0 transmission has been studied by several brokerages. Per a Jefferies India FMCG report from March 2026, the average price reduction taken by listed FMCG players on key SKUs was ~6.5% of MRP (vs. a 13 percentage point tax cut, implying ~50% pass-through). The remaining gap is being captured as margin expansion rather than price reduction. HUL took a 6% MRP cut on key detergent SKUs, 7% on key soap SKUs, and 5% on key shampoo SKUs; Britannia took a 5% MRP cut on key biscuit SKUs; Dabur took a 6% MRP cut on key chyawanprash and hair oil SKUs; Nestle took a 4-5% MRP cut on key Maggi, coffee, and milk-food SKUs. The remaining 6-7 percentage points of tax benefit was retained as gross margin expansion, supporting the EBITDA margin recovery visible in the Q3 and Q4 FY26 prints.

2.7 Recent policy and regulatory developments (Apr 2025 - Jun 2026)

The regulatory regime is net-supportive for the FMCG sector in FY27. The rate environment is easing, the monsoon is forecast to be normal, the government is extending consumption-positive programmes (PLI for food processing, MGNREGA wage hike, rural employment), and there are no major tax-rate negatives on the horizon. The biggest regulatory risk is a potential FSSAI tightening on sugar, salt, and fat content in packaged foods — a draft regulation issued in October 2025 proposes front-of-pack warning labels for products exceeding WHO-recommended thresholds. This is a 2-3 year compliance and reformulation cycle, with low probability of a step-function cost increase in FY27.

3. Index Performance & Technical Setup

The Nifty FMCG index has been one of the most underperforming major indices of the NSE in the three years ending June 2026, with the gap to the Nifty 50 widening to multi-year highs. This section traces the price action, breaks down the relative performance, and lays out the technical setup into FY27.

3.1 Nifty FMCG index — level and returns

The Nifty FMCG index closed at 54,820 on 13 June 2026, up +0.3% YTD (vs. Nifty 50 +9.8% YTD), +4.2% in 1M (vs. Nifty 50 +3.4%), +2.1% in 3M (vs. Nifty 50 +5.6%), +6.8% in 6M (vs. Nifty 50 +11.2%), +8.4% in 1Y (vs. Nifty 50 +18.6%), +12.3% in 3Y CAGR (vs. Nifty 50 +16.2% CAGR), and +9.8% in 5Y CAGR (vs. Nifty 50 +14.4% CAGR). The 5Y relative underperformance to Nifty 50 is ~-23% cumulative (10.0% Nifty 50 cumulative vs. -23.0% Nifty FMCG cumulative on a relative basis over 5 years; specifically, the Nifty FMCG index is up ~60% absolute over 5 years vs. Nifty 50 up ~96% absolute).

Source: NSE close prices as on 13 June 2026. CAGR computed on a compounded basis. Nifty FMCG constituents as on date.

The Nifty FMCG index hit an all-time high of 58,144 on 28 January 2025 and a 52-week low of 49,820 on 7 March 2025. The 1-year range of 49,820–58,144 (16.7% peak-to-trough) is narrower than the broader market's 1-year range (typically 20-25%) but wider than the 3-year average range of 12-14%. The current 13 June 2026 close of 54,820 is 5.7% below the all-time high and 10.0% above the 52-week low, putting the index in the upper third of its 52-week range.

3.2 Nifty FMCG vs. Nifty 50 relative chart

The relative chart of Nifty FMCG to Nifty 50 (rebased to 100 on 1 April 2018) tells the story of the sector's underperformance. The ratio started at 100.0 on 1 April 2018, rose to a peak of 112.4 in March 2020 (the COVID defensive trade), then spent most of 2020-2022 oscillating between 95-110. The decisive break lower came in CY23 as the post-COVID earnings normalisation in HUL, ITC, and Nestle collided with the rapid re-rating of cyclicals, banks, and capital goods. The ratio bottomed at 74.2 in March 2025, a level last seen in early 2017. The ratio has since stabilised in the 76-82 range and closed at 80.1 on 13 June 2026. The 8-year relative chart shows a clear multi-year base formation between 75 and 82, with the 200-day relative moving average at 79.4 and the 800-day relative moving average at 84.3 — meaning the ratio is trading below its long-term mean but above its cyclical low.

Source: NSE, NiftyBrief compilation. Ratio rebased to 100 on 1 April 2018.

The relative-value implication is significant. If the Nifty FMCG / Nifty 50 ratio mean-reverts toward the 8-year mean of 91.2 over the next 24 months, and if the Nifty 50 delivers a 12% CAGR over that period, the Nifty FMCG index would deliver a ~22% CAGR — a substantial outperformance that the market is not pricing in. This is the central re-rating thesis of this report.

3.3 Index technical setup

The Nifty FMCG daily chart shows a 200-day simple moving average (SMA) at 53,420 and a 50-day SMA at 54,180. The 13 June 2026 close of 54,820 is above both, indicating positive medium-term trend. The 14-day RSI at 62.4 is in the upper-neutral zone, suggesting some short-term overbought risk but no extreme. The MACD is in a bullish crossover with the signal line at -180 below the MACD at -120. The Bollinger Band width is at the 38th percentile of the 5-year distribution, indicating a relatively tight trading range with low volatility. The support levels are at 53,400 (200-day SMA), 51,800 (April 2026 low), and 49,800 (March 2025 swing low). The resistance levels are at 55,800 (May 2026 high), 57,200 (February 2026 high), and 58,144 (all-time high).

The Nifty FMCG weekly chart shows a 50-week SMA at 52,200 and a 100-week SMA at 53,800, both of which the index is above. The 14-week RSI at 58.2 is in the neutral zone with a positive bias. The MACD on the weekly is in a bullish crossover since March 2026. The weekly chart's Ascending Triangle pattern is in the process of forming — a flat top at ~58,000-58,500 (resistance) and a rising bottom at ~50,000-54,000 (support from late 2025 to early 2026). A decisive break above 58,500 on heavy volumes would signal a multi-quarter breakout and open the path to 65,000+ on a 12-month view.

3.4 Constituent-level returns and dispersion

The dispersion of returns within the Nifty FMCG index has been wider in the last 12 months than in any 12-month period in the last 5 years. The 1Y return range is from -12.4% (Emami) to +34.6% (Tata Consumer), a 47 percentage point spread. The 3Y CAGR range is from +2.1% (Emami) to +24.8% (Tata Consumer), a 22.7 percentage point spread. The 5Y CAGR range is from +1.8% (Emami) to +19.2% (Britannia), a 17.4 percentage point spread. This dispersion reflects the divergent fundamental trajectories — the volume comeback is benefiting some names (Tata Consumer's tea and coffee pricing, Britannia's international business ramp, HUL's premiumisation) and bypassing others (Emami's distribution challenges, Marico's food business investments).

Source: NSE close prices as on 13 June 2026. CAGR computed on a compounded basis.

The clear outperformer in the 1Y, 3Y, and 5Y windows is Tata Consumer (Tata group's branded foods and beverages platform, with consolidation of Capital Foods, Organic India, and Stellar Health's recent acquisitions), which has compounded at 24.8% over 3Y and 18.4% over 5Y. The clear underperformer is Emami (+2.1% over 3Y, +1.8% over 5Y), which has been struggling with distribution slippage in the post-pandemic period and increased competition in the cool oil and balm categories.

3.5 Nifty FMCG vs. global FMCG benchmarks

For international context, we compare the Nifty FMCG index performance to the MSCI India Consumer Staples index, the S&P 500 Consumer Staples index, the MSCI EM Consumer Staples index, and the Straits Times Index Food & Beverage sub-index over 1Y, 3Y, and 5Y.

Source: Bloomberg, MSCI, NSE, S&P, Singapore Exchange as on 13 June 2026. CAGR compounded in USD.

The Nifty FMCG has been the best-performing major FMCG benchmark globally over 3Y and 5Y, despite the underperformance to the Nifty 50. The Sharpe ratio of 0.62 over 5Y is respectable, although below the Nifty 50's 5Y Sharpe of 0.74. The Nifty FMCG's outperformance vs. global FMCG is driven by (a) India's higher consumption growth (6-8% nominal vs. 2-4% for developed markets), (b) the structural premiumisation of Indian consumer baskets, and (c) the dominance of large-cap, cash-generative platform incumbents (HUL, ITC, Nestle India) that trade at premium multiples globally.

3.6 Implied volatility and options positioning

The Nifty FMCG 30-day implied volatility index closed at 14.2% on 13 June 2026, in the 38th percentile of the 3-year distribution (range: 9.8% to 31.4%). The IV is well below the Nifty 50's 30-day IV of 16.4%, reflecting the lower volatility of FMCG cash flows. The Nifty FMCG futures basis (1-month) is at +18 bps premium to spot, indicating mild positive roll yield for short futures positions. The Nifty FMCG options put-call ratio is at 0.92 (puts / calls) on the weekly expiry, indicating modest hedging demand but no panic. The max pain level for the 19 June 2026 weekly expiry is 54,500, meaning option sellers are positioned for the index to gravitate toward that level at expiry. The open interest concentration in 56,000-58,000 calls and 52,000-53,000 puts suggests the market expects a sideways-to-mildly-bullish tape through the June-July 2026 window.

The technical and options setup is mildly bullish but not yet at a breakout. The combination of low IV, mild positive basis, modest put-side hedging, and the ascending-triangle base formation creates a favourable risk-reward for a 12-18 month view, with the path to a 65,000 target (12-15% upside from spot) requiring the volume comeback thesis to play out as expected.

4. Macro Overlay

The Indian macro setting in mid-2026 is, on balance, the most supportive it has been for the FMCG sector in three years. The four macro variables that matter most for FMCG are real wage growth, monsoon, inflation (especially food inflation), and interest rates. All four are aligned favourably in mid-2026.

4.1 RBI policy and the rate cycle

The RBI repo rate stands at 5.75% as of 13 June 2026, after a cumulative 125 basis points of cuts in CY26 (the first 25 bps cut came in February 2026, followed by 50 bps in April 2026, and 50 bps in June 2026). The terminal rate for this cycle is expected to be 5.25% by Q4 CY26 (an additional 50 bps of cuts), based on the RBI's April 2026 Monetary Policy Committee (MPC) minutes and a survey of 18 economists by Bloomberg in May 2026. The policy stance is "neutral" since the February 2026 meeting, having shifted from "withdrawal of accommodation" in October 2025.

The implications for FMCG are mildly positive to neutral. Lower rates reduce borrowing costs for distributors and retailers, support credit-fueled consumption (cars, two-wheelers, durables, premium FMCG), and tend to compress bond yields (modest negative for FMCG dividend yield, but the yield gap to Nifty 50 remains wide at ~90 bps). The CRR and SLR remain at 4% and 18% respectively, providing adequate banking system liquidity.

The bond yield curve is normalising. The 10-year G-Sec yield is at 6.62% on 13 June 2026, down from 7.04% in October 2025. The 2-year G-Sec yield is at 5.84%, indicating market expectations of further short-term rate cuts. The Nifty FMCG dividend yield of 2.3% is now less attractive relative to the 10-year G-Sec yield of 6.62% than at any time in 10 years — historically the Nifty FMCG dividend yield was 100-200 bps below the 10-year G-Sec yield, and the current spread of 432 bps reflects the market's preference for fixed income over FMCG equity. This spread is the second widest in 15 years (only the COVID-era 480 bps spread in March 2020 was wider) and represents a structural overhang on FMCG valuations.

4.2 USD/INR and currency

The USD/INR closed at ₹83.42 on 13 June 2026, having traded in a narrow range of ₹82.60-₹84.20 over the last 6 months. The RBI has been active in managing the rupee through periodic dollar sales and the FPI flow channel. The real effective exchange rate (REER) of the rupee is at 101.4 (June 2026), marginally above the 100 neutral mark and consistent with mild overvaluation. The forward curve is at a 0.6% premium to spot for 3-month forwards and 1.8% for 12-month forwards, suggesting the market expects mild rupee depreciation over the next year.

The currency impact on the FMCG sector is mixed. HUL and Nestle India have meaningful import content (palm oil, packaging, fragrances, flavours) and benefit from a weaker rupee (imports more expensive, but pricing power allows them to pass through). ITC and Britannia have export businesses (ITC's paperboards and agri exports, Britannia's international operations in the Middle East and Africa) and benefit from a weaker rupee. Marico has significant international revenue (40-45% of total) from Bangladesh, Vietnam, the Middle East, and Africa — a weaker rupee boosts reported international revenue. Tata Consumer has international coffee operations (Tata Coffee, Eight O'Clock Coffee in the US, Tata Consumer Solutions UK) — a weaker rupee is positive for reported revenue. Emami has international operations (Men's grooming brands in the Middle East, Africa, and Asia) — a weaker rupee is mildly positive. The net sector exposure is mildly positive to a weaker rupee, with the most exposure at Marico and ITC.

4.3 Crude oil and the petrochemical chain

The Brent crude closed at $69.40/bbl on 13 June 2026, having traded in a range of $66-78 over the last 6 months. The OPEC+ supply discipline, the gradual unwinding of the 2.2 mbpd voluntary cut through 2026, the US shale production growth at ~+0.3 mbpd YoY, and the muted China demand growth are all weighing on prices. The forward curve is in modest backwardation (3-month at $68.20, 12-month at $66.80), suggesting the market expects further mild weakness.

The FMCG sector is a net beneficiary of lower crude through three channels: (1) Lower HDPE/LDPE/PET packaging cost (crude-linked petrochemicals account for ~12-18% of total FMCG COGS for the universe), (2) Lower logistics and freight cost (diesel at ₹87-89/litre vs. ₹92-95 a year ago, freight rates down ~8% YoY for road and ~12% YoY for rail), and (3) Lower surfactant cost (LABSA, SLES, and other detergent intermediates are crude-linked). The gross margin tailwind for FY27 from lower crude is ~30-50 bps for the universe, with the largest beneficiaries being HUL (home care, personal care), Godrej CP (home care), and Dabur (packaging).

4.4 Global rate cycle and the EM consumer

The US Federal Reserve is expected to cut rates by 75-100 bps in CY26 (from 4.50% currently, per the Fed Funds futures pricing as of 13 June 2026), bringing the terminal rate to 3.50-3.75% by end-CY26. The European Central Bank is expected to cut by 50-75 bps (from 2.50% currently). The Bank of England is expected to cut by 75-100 bps (from 4.00%). The Bank of Japan is the only major central bank tightening, with rates at 0.75% and expected to rise to 1.00-1.25% by end-CY26.

The implications for the Indian FMCG sector are positive. (1) Lower US/Europe rates compress the dollar's relative attractiveness, supporting the rupee (or at least limiting the depreciation) and reducing the cost of imported inputs. (2) Lower US rates typically trigger EM equity inflows, which support valuations across the Indian market, including FMCG. (3) Lower global rates ease the financing conditions for Indian FMCG companies' international acquisitions (Marico's M&A pipeline, Godrej CP's Africa expansion, Tata Consumer's international M&A). (4) The JP Morgan EM Bond Index inclusion of India government bonds (which completed in June 2024) continues to support portfolio inflows, and the FTSE Russell EM Government Bond Index inclusion (which completed in September 2025) is the second leg of this flow, with ~$30 billion of passive flows estimated to have come into Indian bonds over 18 months.

4.5 Government policy — rural, food, and consumption

The Union Budget FY27 (presented on 1 February 2026) was mildly consumption-positive with the following key allocations:

The PMGKAY (Pradhan Mantri Garib Kalyan Anna Yojana), the free-food-grain scheme covering ~80 crore beneficiaries, was extended for 5 years in the FY27 budget at a total outlay of ₹11.8 lakh crore, which is a direct support to the bottom 30% of the consumption pyramid and a positive for branded staples (Atta, rice, edible oil) volume growth.

The GST compensation to states issue, which had been a source of fiscal tension through 2024-2025, has been resolved with the 22nd Finance Commission's recommendations (released in August 2025), providing states with a 5-year back-ended compensation formula linked to nominal GDP growth. This removes a major fiscal-uncertainty overhang for the central government and supports the case for stable indirect tax rates through FY30.

4.6 The 2026 monsoon and rural outlook

The India Meteorological Department's (IMD) first stage forecast for the 2026 southwest monsoon, released in April 2026, projected rainfall at 96% of the Long Period Average (LPA) with a model error of ±5%. The LPA is defined as the 87 cm average for the 1971-2020 base period. The forecast is a "normal" monsoon (normal is defined as 96-104% of LPA). The second stage forecast (released in May 2026) revised the estimate to 97% of LPA with the same model error, retaining the "normal" classification. The spatial distribution is forecast to be favourable for the central, western, and southern regions (which are the largest kharif sowing areas), and the temporal distribution is expected to be normal with no extended dry spells.

The agricultural outlook for kharif 2026 is positive: kharif sowing typically starts in mid-June and the early sowing data from the Ministry of Agriculture (released in early June 2026) shows kharif area sown at 6.2 million hectares as of 6 June 2026, up +8% YoY from the same period in 2025 (which was a sub-normal monsoon year). The major kharif crops (rice, pulses, coarse cereals, oilseeds, sugarcane, cotton, jute) are showing early sowing momentum, particularly in Madhya Pradesh, Maharashtra, Karnataka, and Andhra Pradesh.

The rural consumption outlook is decisively favourable for FY27: (a) the monsoon is forecast to be normal, supporting kharif output and rural income; (b) the MGNREGA wage hike of 6% in Q1 CY26 is feeding into rural discretionary spending; (c) the PM-KISAN ₹6,000/year direct cash transfer is in its 18th instalment in May 2026; (d) the rabi crop output for 2025-26 was strong (foodgrain output estimated at 164.7 million tonnes, up 4.2% YoY); (e) two-wheeler sales (a strong proxy for rural discretionary income) were up +12.4% YoY in FY26; (f) tractor sales were up +8.2% YoY in FY26; (g) rural FMCG sales growth was +8.2% YoY in CY25 (NielsenIQ), the strongest in 5 years.

4.7 Inflation — the key input cost cycle

The CPI inflation for May 2026 came in at 3.84% YoY, well within the RBI's 4% target. The CPI food inflation was 3.12% YoY (vs. 6.2% in May 2025), the lowest in 6 years. The CPI core inflation (excluding food and energy) was 4.32% YoY, consistent with mild demand-pull. The WPI inflation for April 2026 was 1.62% YoY (vs. 2.84% in April 2025), reflecting the favorable commodity cycle.

The input cost cycle is in a decisive downcycle. The composite FMCG input basket (weighted by category-specific COGS share) was down -6.8% YoY in FY26 and is forecast to be down another -3.4% YoY in FY27. The components are summarised below.

Source: MCX, BMD, NCDEX, Refinitiv, company filings, NiftyBrief compilation. FY27E based on April-May 2026 spot and 12-month forward curve.

The gross margin tailwind for FY27 is +50-120 bps for the universe, with the largest beneficiaries being:

• HUL (~80-100 bps tailwind) — large home care and personal care exposure
• Marico (~100-120 bps) — large coconut oil and value-added edible oils exposure
• Dabur (~80-100 bps) — chyawanprash, hair oils, ayurvedic
• Emami (~70-90 bps) — mentha-based products, large mentha oil exposure
• Godrej CP (~60-80 bps) — home care, HI, personal care
• ITC (~30-50 bps) — less input-sensitive, but packaging benefits
• Britannia (~40-60 bps) — dairy, wheat, packaging
• Nestle India (~50-70 bps) — milk solids, packaging, coffee
• Tata Consumer (~40-60 bps) — tea, coffee, salt
• Colgate-Palmolive (India) (~50-70 bps) — concentrate, packaging

4.8 Demographic and structural drivers

The demographic setup for Indian FMCG is the most favourable globally. India added 12 million middle-class consumers in the 5 years from CY20 to CY25 (per a McKinsey India report), and is projected to add another 35 million by CY30. The median age of India's population is 28.4 years (vs. China's 39.6 years), the urbanisation rate is at 36.5% (vs. China's 65%) and is growing at 1.2 percentage points per year, and the female labour force participation is at 31.7% (vs. China's 60%) with gradual improvement. Each of these vectors is a multi-decade tailwind for FMCG volume growth.

The rural-urban consumption gap is a key part of the FY27 thesis. The rural per-capita FMCG spend is estimated at ₹6,800/year (CY25) vs. urban per-capita FMCG spend of ₹18,200/year (CY25), a 2.7x gap. A 5% convergence (rural growth faster than urban) would imply a ₹1,100/year increase in rural per-capita FMCG spend by CY30, which translates to ~₹80,000 crore of incremental rural FMCG TAM by CY30. This is a 7-8% TAM expansion on top of the base growth — and a critical pillar of the volume comeback narrative.

5. Sub-verticals & Business Mix

The Nifty FMCG universe spans four primary sub-verticals (Foods & Beverages, Personal Care, Home Care, Tobacco) and two secondary sub-verticals (Stationery, Agarbatti & Matchbox) that contribute marginally. Each name has a distinct category mix, and the aggregate revenue and EBITDA mix is dominated by Foods & Beverages and Personal Care.

5.1 Sub-vertical revenue and EBITDA contribution (FY26)

Source: Company annual reports FY26, screener.in consolidated, NiftyBrief compilation. Nifty FMCG aggregate revenue for FY26 is ~₹2.41 lakh crore.

The sub-vertical mix shows the disproportionate profit contribution of cigarettes — a sub-vertical that is only 12% of revenue but 21% of EBITDA, with a 50% EBITDA margin. The cross-subsidy from cigarettes funds ITC's FMCG-Others (foods, personal care) capex and the conglomerate's diversification into hotels, paperboards, agri, and ITC e-Choupal. The foods and beverages bucket has the largest revenue share (47%) but a more modest EBITDA margin (19.4%) and is the primary growth engine of the sector.

5.2 Sub-vertical 1 — Foods & Beverages

The foods and beverages sub-vertical is the largest and most competitive, spanning biscuits, dairy, packaged foods, beverages, tea, coffee, salt, snacks, ready-to-eat, infant nutrition, and confectionery. The Nifty FMCG universe has a ~₹1,12,500 crore revenue exposure to this sub-vertical in FY26, dominated by Nestle India, ITC Foods, Britannia, Tata Consumer, and Marico Foods (Saffola, Livon, Kaya).

Key sub-trends in foods for FY27:

• Biscuits and baked goods — volume growth recovering, pricing stable, ITC Aashirvaad, Britannia, and Parle (unlisted) are the key players
• Dairy and dairy derivatives — fragmented market with Amul (unlisted, dominant), Mother Dairy (unlisted), Hatsun Agro (listed, small-cap), and Britannia as a niche player; the listed FMCG names are net buyers of milk and SMP
• Tea — Tata Consumer, HUL (Brooke Bond, Taj Mahal, Red Label), Wagh Bakri (unlisted), and Twinings (HUL distributed) are the key players; volume growth is muted (1-2% in CY25) due to category maturity
• Coffee — Tata Consumer (Eight O'Clock US, Tata Coffee India), Nestle (Nescafe), HUL (Bru), and a long tail of small premium brands (Blue Tokai, Rage Coffee, Third Wave); the premium coffee sub-category is growing at 18-22% YoY
• Packaged staples (Atta, rice, pulses, besan) — ITC Aashirvaad, Tata Sampann, Patanjali, Adani (unlisted), and a long tail; volume growth in atta is robust at 8-12% YoY
• Snacks (branded, organised) — ITC Bingo, PepsiCo (unlisted), Haldiram's (unlisted/listed partly), Bikaji (listed, small-cap), Prataap Snacks (listed, small-cap), Britannia Treat, and the D2C disruptors (Cornitos, Snackible, Yoga Bar); the branded organised snacks market is growing at 14-16% YoY
• Edible oils — Marico Saffola, Adani Wilmar (listed, large-cap), Cargill (unlisted), and a long tail; the listed FMCG names have small direct exposure, but copra-based oils are large for Marico
• Confectionery — Nestle, Mondelez (unlisted), Mars (unlisted), ITC (Fabelle premium), Lotte (unlisted), Perfetti (unlisted); the listed FMCG names have small direct exposure
• Spices — MDH (unlisted), Everest (unlisted), Catch (unlisted, but has D2C), ITC Aashirvaad, Tata Sampann; the listed FMCG names have growing exposure
• Honey, chyawanprash, health foods — Dabur, Patanjali (unlisted), Zandu (Emami), and a long D2C tail (Zoooma, Honeytwigs, Apis Himalaya)
• Ready-to-eat, ready-to-cook — MTR (listed separately as MTRE), ITC, Britannia, Ching's (unlisted), and a long D2C tail (Tender Cuts, FreshToHome, Licious)
• Infant nutrition, baby food — Nestle (Lactogen, Cerelac, Nan), Danone (unlisted), HUL (out of scope), and a long D2C tail (Mylo, Mamaearth); the category is growing at 10-12% YoY
• Pet food — Mars, Nestle Purina (unlisted), and a long D2C tail (Heads Up For Tails, PetKonnect); category growing 20%+ but small base

5.3 Sub-vertical 2 — Personal Care

The personal care sub-vertical spans hair care, skin care, oral care, deodorants, body wash, soaps, baby care, men's grooming, colour cosmetics, and fragrances. The Nifty FMCG universe has a ~₹57,800 crore revenue exposure in FY26, dominated by HUL (Beauty & Personal Care), Marico, Dabur, Godrej CP, Emami, and Colgate-Palmolive (India).

Key sub-trends in personal care for FY27:

• Hair oils (coconut, mustard, perfumed, value-added) — fragmented market, Marico and Dabur dominate; the D2C disruptors (mamaearth, WOW, Traya) are at <3% share
• Hair care (shampoo, conditioner, masks) — HUL dominant with Clinic Plus, Dove, TRESemmé, Sunsilk; the D2C disruptors are taking 1-2% per year
• Skin care (face wash, moisturiser, sunscreen, anti-ageing) — fragmented; HUL (Pond's, Dove), Marico (Kaya), and a long D2C tail (mamaearth, Plum, Minimalist, Dot & Key)
• Soaps (beauty, premium, medicated, ayurvedic) — HUL (Lifebuoy, Lux, Dove, Pears) and Godrej CP (Cinthol, No.1) dominate; the unbranded and regional segments are large
• Oral care (toothpaste, toothbrush, mouthwash, floss) — Colgate-Palmolive India dominant with ~52% toothpaste share; HUL (Close-Up, Pepsodent, Lever Ayush) and Dabur (Meswak, Red) are the secondary players
• Deodorants — HUL (Axe, Dove), Godrej (Aer), and a long tail (Wild Stone, Fogg, Park Avenue, Set Wet) — fragmented and competitive
• Men's grooming (beard, hair, skin) — Emami (Fair & Handsome), Marico (Set Wet, Livon), HUL (Axe), and a long D2C tail (Beardo, Bombay Shaving, Ustraa, mCaffeine)
• Colour cosmetics — Lakme (HUL), Lotus Herbals, Sugar, L'Oreal (unlisted), Maybelline (unlisted); the listed FMCG names have small direct exposure
• Fragrances — mostly unlisted (Ajmal, Denver, Bella Vita, Skinn by Titan); the listed FMCG names have small exposure
• Ayurvedic / natural — Dabur, Emami (Zandu), Patanjali (unlisted), Himalaya, Lotus Herbals, and a long D2C tail (mamaearth, WOW, Juicy Chemistry)

5.4 Sub-vertical 3 — Home Care

The home care sub-vertical spans laundry detergents, dishwash, toilet cleaners, floor cleaners, surface disinfectants, fabric conditioners, and mosquito repellents. The Nifty FMCG universe has a ~₹41,200 crore revenue exposure in FY26, dominated by HUL (Home Care), Godrej CP (Home Care), and Dabur (Home Care).

Key sub-trends in home care for FY27:

• Laundry detergents (powder, liquid, pods, bars) — HUL dominant with Surf Excel, Rin, Wheel; the D2C disruptors are at <2% share; liquid detergents growing at 18-22% YoY (vs. powder at 4-5%)
• Dishwash (bars, liquid, pods) — HUL (Vim) dominant, with Pril (unlisted), and the unbranded segments; liquid dishwash growing at 14-16% YoY
• Toilet cleaners, floor cleaners, surface cleaners — HUL (Domex, Lizol), Reckitt (Lizol in some markets), and a long D2C tail (TheBetterHome, CultClean); the category is seeing premiumisation
• Mosquito repellents (coils, vaporisers, liquids, cards, patches) — Godrej (All Out, Hit), Dabur (Odonil, Odomos), SC Johnson (unlisted); coils volume is declining, vaporisers and liquids growing
• Fabric conditioners — HUL (Comfort) and a long tail (Lenor, Snug); growing at 10-12% YoY
• Disinfectants, sanitiser, handwash — post-COVID normalisation, but base effects are still showing in numbers

5.5 Sub-vertical 4 — Tobacco & Cigarettes

The tobacco and cigarettes sub-vertical is dominated by a single listed player — ITC — which has a de-facto monopoly on the Indian legal cigarette market with a market share of ~78% (per a Markets and Markets report from CY25, the remainder is split between Godfrey Phillips, VST Industries, and a small import segment). The Nifty FMCG universe has a ~₹28,400 crore revenue exposure in FY26, almost entirely from ITC.

Key sub-trends in tobacco for FY27:

• Excise duty increases — the annual excise hike in the Union Budget has been 6-8% in recent years, and the GST 2.0 regime increased the tax incidence on cigarettes to 40% (sin slab)
• Volume contraction — legal cigarette volumes are declining at 2-3% per year due to higher taxes, regulatory pressure (COTPA), and the growth of illicit trade (estimated at 25-30% of total consumption)
• Premiumisation — ITC is skewing mix toward premium and super-premium brands (Classic Connect, Gold Flake Kings, Wills Navy Cut, Flake Excel), supporting revenue per stick and segment EBITDA margin
• Other tobacco (bidi, chewing, hookah, e-cigarettes) — the bidi and chewing segments are dominated by unorganised players, while e-cigarettes are regulated (banned in many states)
• ITC's strategic focus — the conglomerate continues to diversify away from cigarettes (the segment's share of ITC's revenue has fallen from 67% in FY15 to 36% in FY26), but the segment's share of EBITDA remains ~62% and the share of PAT remains ~75%. The demerger of the hotels business (effective 1 January 2025) further de-emphasises the non-cigarette FMCG and clarifies the cigarette-conglomerate structure.

5.6 Business mix of the top 10 names

Source: Company annual reports, investor presentations FY26. Numbers in ₹ crore. Other includes paperboards, packaging, agri, stationery, agarbatti (mainly ITC), and others.

The table shows the category concentration of the universe: 4 pure-play names (Nestle, Britannia, Colgate, Emami) with single-category focus, 4 diversified names (HUL, ITC, Dabur, Godrej CP) with multi-category mix, and 2 multi-category-but-leveraged-to-one names (Marico — leveraged to PC, Tata Consumer — leveraged to F&B). The diversified names tend to have lower revenue volatility, broader distribution synergies, and lower single-category execution risk; the pure-plays tend to have higher margins, more focused capital allocation, and higher sensitivity to single-category cycles.

5.7 EBITDA margin profile

The EBITDA margin profile of the Nifty FMCG universe reflects the category mix and the brand strength of each name. The aggregate EBITDA margin is ~26.3% in FY26, with significant dispersion from 14% (Tata Consumer) to 50% (ITC cigarettes, blended). The category-level margin profile is summarised below.

The margin direction is the most important sub-text: HUL, Colgate, and ITC-FMCG-Others are expanding; Marico, Dabur, and Emami are compressing; the rest are stable. The HUL expansion is driven by premiumisation, gross margin tailwind, and operating leverage on volume growth. The Colgate expansion is driven by premiumisation (Visible White, Total, Optic White lines), input cost tailwind, and modern trade channel mix. The ITC-FMCG-Others expansion is driven by scale-up of foods, stationery, and personal care (the segment has been sub-scale and unprofitable for years; FY26 was the inflection).

The Marico compression is the most concerning — the Saffola foods expansion (acquisition of True Elements, Z Pure, and the planned ₹1,200 crore capex on a new Sanand foods plant) is dragging consolidated EBITDA margin from 19.6% (5Y avg) to 17.1% in FY26. The Dabur compression is driven by higher A&P spend in a bid to defend market share against D2C disruptors, and Emami's compression is driven by distribution slippage in the post-pandemic period and the Kesh King brand's underperformance vs. expectations.

6. Top 10 Constituents Deep Dive

This section provides a 350-word deep dive on each of the top 10 Nifty FMCG constituents. The structure for each: (1) Business, (2) Latest Q3/Q4 FY26 revenue/EBITDA/PAT, (3) Margin trend, (4) Growth driver, (5) Risk, (6) Valuation vs. 5Y.

6.1 Hindustan Unilever (HINDUNILVR) — Nifty FMCG heavyweight, the bellwether

Business. Hindustan Unilever is the Indian subsidiary of Unilever plc (UK) and the largest FMCG company in India by market cap (₹5,09,579 cr / US$61 bn). The portfolio spans four segments — Beauty & Personal Care (~44% of revenue), Home Care (~35%), Foods & Refreshment (~7%), and Other (Ice cream distribution, Exports, others ~14%). The brand portfolio includes Lifebuoy, Lux, Dove, Pears, Surf Excel, Rin, Wheel, Vim, Domex, Pond's, Lakme, Clinic Plus, Sunsilk, TRESemmé, Bru, Kissan, Annapurna, Kwality Wall's (distribution), Pureit, and dozens of others. The HUL distribution reaches ~9 million retail outlets directly and ~3 million more through Project Shakti rural entrepreneurs. The company operates 28+ manufacturing facilities across India. The promoter is Unilever plc with a 61.9% stake (subject to the simplification of the Unilever dual-listed structure post the failed 2022 Unilever-GSK Consumer Healthcare merger, which remains under review).

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹16,441 cr (flat YoY, +0.5%) with OPM of 23% and PAT of ₹6,603 cr (boosted by a one-time tax benefit and Other Income of ₹4,048 cr linked to a treasury restructuring gain). Q4 FY26 (Jan-Mar 2026) revenue of ₹16,351 cr (flat YoY) with OPM of 23% and PAT of ₹2,994 cr (-2% YoY, normalised for Q3 base). Underlying volume growth accelerated from 1% in H1 to 5% in Q4 FY26. The full-year FY26 revenue was ₹64,468 cr (+0.5% YoY, depressed by the SKU rationalisation and the lapping of the strong H1 base). PAT was ₹15,059 cr (+41.2% YoY, but distorted by the one-time Q3 boost).

Margin trend. EBITDA margin has been stable in the 23-25% range over the last 5 years (FY22: 24.6%, FY23: 23.8%, FY24: 22.6%, FY25: 23.7%, FY26: 23.3%). The compression in FY24 was driven by softer volume and input cost spikes (palm oil, surfactants); the recovery in FY25-FY26 was driven by gross margin expansion from input cost easing, premiumisation, and operating leverage on volume. The premium portfolio (TRESemmé, Dove, Pond's, Lux, Clinique, Vaseline, Lakme) now contributes ~32% of revenue (vs. 22% in FY21), and is the key margin driver.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration to 5-7% (vs. 1-3% in FY24-FY25), driven by rural recovery and the GST 2.0 anniversary base; (2) Premium portfolio scaling from 32% to 38% of revenue by FY28; (3) New categories (D2C, beauty-tech, health & wellness, sustainability) — HUL acquired Zywie Ventures (parent of Wellbeing Nutrition, listed separately), OZiva, and is incubating several D2C brands (Love & Care, Magic; in 2024-2025); (4) Distribution expansion to 12 million outlets (from 9 million today) by FY28; (5) Operating leverage on volume growth, with each 100 bps of volume growth translating to ~40-50 bps of EBITDA margin expansion.

Risk. The principal risks are (1) rural recovery delay (any 6-month delay in the rural cycle would compress FY27 volume growth to 3-4%), (2) competition from D2C disruptors in beauty, hair care, and premium personal care, (3) execution risk on premiumisation (the mass and premium portfolios require different distribution and marketing muscles), (4) regulatory risk on FSSAI, EPR, and sugar/salt/fat labelling, and (5) parent-strategy risk (Unilever plc's global strategy of "focus on premium, scale up in US/EU/China" could mean lower capital allocation to India, although HUL's cash generation makes this self-funding).

Valuation vs. 5Y. HUL trades at TTM P/E of 33.5x and P/B of 8.2x, vs. the 5Y average of 38.4x P/E and 9.8x P/B. The stock is trading at a ~13% discount to its 5Y average P/E, reflecting the market's caution on volume growth and the relative underperformance of FMCG vs. broader Nifty. The forward P/E (FY27E EPS of ₹68) is 30.0x, and the EV/EBITDA (FY27E) is 24.4x. The dividend yield is 1.89% (vs. 5Y average of 2.4%). The valuation is fair to mildly attractive — a 12-18 month view sees a 12-18% total return in a base case, with upside if volume growth surprises positively.

6.2 ITC — Cigarette cash machine, conglomerate play, FMCG turnaround

Business. ITC Ltd is the largest cigarette manufacturer in India (~78% market share) and a diversified conglomerate with six business segments — Cigarettes (FMCG, ~36% of revenue), FMCG-Others (~21%), Hotels (~4%), Paperboards & Packaging (~22%), Agri Business (~14%), and Others (~3%). The company is part of the ITC Group (spearheaded by the BAT-related and Indian-diversified holdings), with the tobacco heritage dating to 1910. The cigarette portfolio includes Classic, Gold Flake, Wills, Berkeley, Flake, India Kings, and Bristol; the FMCG-Others portfolio spans Aashirvaad, Sunfeast, Bingo, YiPPee, Candyman, B Natural, Vivel, Fiama, Engage, Savlon, Classmate, Paperkraft, and dozens of others; the hotels portfolio spans 130+ properties (ITC Hotels, demerged and separately listed as ITC Hotels in January 2025); the paperboards and packaging spans BILT, ITC PSPD; the agri business spans leaf tobacco, e-Choupal, wheat, soya, spices, coffee; the others span ITC Infotech (now demerged).

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹20,047 cr (+4.8% YoY) with OPM of 34% and PAT of ₹5,018 cr (-3% YoY, normalised). Note: the Q3 FY25 print included the one-time gain on the demerger of ITC Hotels (effective 1 January 2025), which added ~₹14,000 cr to FY25 PAT. Q4 FY26 (Jan-Mar 2026) revenue of ₹17,825 cr (+1.8% YoY) with OPM of 39% (boosted by cigarette price increases taken in early Q4) and PAT of ₹5,470 cr (+9% YoY). The full-year FY26 revenue was ₹78,868 cr (+4.7% YoY) and PAT was ₹21,018 cr (-40.1% YoY, distorted by the FY25 demerger gain).

Margin trend. Consolidated EBITDA margin has been stable in the 33-37% range over the last 5 years (FY22: 36.2%, FY23: 36.0%, FY24: 36.8%, FY25: 33.7%, FY26: 34.6%). The cigarette segment EBITDA margin has been in the 53-57% range (FY22: 56.4%, FY23: 55.2%, FY24: 54.8%, FY25: 54.2%, FY26: 55.0%). The FMCG-Others segment EBITDA margin has improved from 2.8% in FY20 to 6.8% in FY26 — the segment has been sub-scale and unprofitable for a decade, and is at an inflection point. The paperboards EBITDA margin is in the 22-26% range and the agri EBITDA margin is in the 5-7% range (a low-margin commodity business).

Growth driver. The FY27 growth case rests on 5 vectors: (1) Cigarette pricing power — the segment takes 6-8% excise duty increases in the budget and passes through with 4-6% MRP increases, plus 2-3% mix premiumisation; (2) FMCG-Others scaling — the segment is now at ~₹16,800 cr revenue, with the breakeven point crossed in FY26 and the path to a 10% segment EBITDA margin by FY28; (3) Hotels ramp — the demerged entity is benefiting from the post-COVID leisure and business travel cycle; (4) Paperboards and packaging benefiting from e-commerce and FMCG growth; (5) Capital allocation — ITC has a ₹48,000 cr cash pile and a stated intent to return excess cash to shareholders (the dividend payout has been 80-100% in recent years, with the buyback frequency rising).

Risk. The principal risks are (1) Cigarette volume contraction at 2-3% per year due to tax hikes and COTPA regulatory pressure; (2) Illicit cigarette trade at 25-30% of total consumption, which depresses legal volumes; (3) FMCG-Others execution risk — the segment is at an inflection but the path to a 10% segment EBITDA margin requires continued operating leverage, which is not guaranteed; (4) ESG/governance risk — ITC is the subject of ongoing SEBI and shareholder activism on capital allocation, related-party transactions, and the hotel demerger structure; (5) Agri and paperboard cycle — these are commodity-linked and have limited pricing power.

Valuation vs. 5Y. ITC trades at TTM P/E of 17.1x and P/B of 4.6x, vs. the 5Y average of 20.4x P/E and 5.2x P/B. The stock trades at a ~16% discount to its 5Y average P/E, reflecting the market's concern on the cigarette volume trajectory and the FMCG-Others profitability path. The forward P/E (FY27E EPS of ₹17.5) is 16.5x, and the EV/EBITDA (FY27E) is 11.8x. The dividend yield is 5.09% (vs. 5Y average of 4.2%), the highest in the Nifty FMCG universe. The valuation is attractive for a high-quality, cash-generative, slowly-growing franchise with a 5%+ dividend yield. A 12-18 month view sees 15-22% total return in a base case.

6.3 Nestle India — The premium foods compounder

Business. Nestle India is the Indian subsidiary of Nestle SA (Switzerland) and the largest listed pure-play foods company in India (₹2,65,278 cr market cap / US$32 bn). The company operates in a single segment — Foods — spanning Maggi (noodles, sauces, masala), Nescafe (coffee), Milkmaid (condensed milk), KitKat, Munch, Bar One, Eclairs (chocolates and confectionery), Cerelac, Lactogen, Nan, Nestogen (infant nutrition), Maggie Ketchup, Maggi Masala-ae-Magic, and Cerelac. The Maggi noodle brand is the largest single FMCG brand in India by retail value, with ~78% market share in the branded noodles category. The company operates 9 manufacturing facilities in India (Ponda, Moga, Bicholim, Samalkha, Tahliwal, Nanjangud, Choladi, Sanand, and the new capex project at Lakshmi Hosur). The promoter is Nestle SA with a 62.76% stake (post the November 2024 simplification of the parent structure).

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹5,667 cr (+5.2% YoY) with OPM of 21% and PAT of ₹998 cr (+34% YoY, boosted by a one-time tax benefit). Q4 FY26 (Jan-Mar 2026) revenue of ₹6,748 cr (+15.5% YoY) with OPM of 26% and PAT of ₹1,111 cr (+18% YoY). The full-year FY26 revenue was ₹23,155 cr (+14.6% YoY) and PAT was ₹3,499 cr (+9.1% YoY). The Q4 print was the highest quarterly revenue and PAT in the company's history, with broad-based growth across Maggi, Maggi Ketchup, KitKat, and the chocolate portfolio. The chocolate portfolio crossed ₹1,000 cr annualised revenue for the first time.

Margin trend. EBITDA margin has been stable in the 22-25% range over the last 5 years (FY22: 24.6%, FY23: 23.4%, FY24: 23.0%, FY25: 24.0%, FY26: 22.7%). The compression in FY26 was driven by higher cocoa prices (cocoa bean prices were up 60-80% YoY in CY25) and higher milk solids cost in H1 FY26, both of which eased in H2 FY26. The Maggi noodles segment has a 28-30% gross margin and ~22% EBITDA margin, the coffee segment has a ~25% gross margin and ~18% EBITDA margin, and the confectionery segment has a ~30% gross margin and ~20% EBITDA margin. The out-of-home consumption (modern trade, e-commerce) channels are now ~28% of revenue (vs. 18% in FY22), and have higher gross margins.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration to 6-8% (vs. 2-3% in FY25), driven by Maggi noodles (the largest single brand), Maggi Ketchup (growing at 35%+), and the new launches (Maggi Korean, Maggi Pizza, Maggi Hot & Sweet); (2) Premium portfolio scaling — KitKat, Munch, Bar One, and the new premium chocolate launches (Nestle Docello desserts, Nestle Milk Chocolate premium SKUs) growing at 18-22% YoY; (3) Out-of-home consumption — coffee (Nescafe) and confectionery are benefiting from the cafe and convenience store boom; (4) E-commerce and quick commerce — Nestle India is the largest FMCG supplier on quick commerce platforms (Blinkit, Zepto, Instamart) and is taking 4-6% of revenue from this channel; (5) Capacity expansion — the new Sanand plant (₹700 cr capex, commissioned in CY26) and the planned Lakshmi Hosur expansion will support 15% revenue CAGR over the next 3 years.

Risk. The principal risks are (1) Input cost spikes — cocoa, milk solids, sugar, wheat, palm oil are the key inputs and are subject to global commodity volatility; (2) Maggi noodles sensitivity — the single brand is ~40% of revenue, and any category-level event (e.g., the 2015 lead-in-Maggi crisis, the 2017 Maggi-Oats launch by ITC) can have an outsized impact; (3) Parental capital allocation — Nestle SA's "global growth platform" strategy could mean higher capex requirements, although Nestle India has been self-funding its capex; (4) Premium chocolate category competition — Mondelez (unlisted, dominant), Lotte, Mars, ITC Fabelle, and the D2C disruptors (Go Desi, BeeTee's Melt) are all in the premium chocolate battleground; (5) Concentration in domestic — the company has negligible exports (~3% of revenue) and is fully leveraged to Indian consumption.

Valuation vs. 5Y. Nestle India trades at TTM P/E of 77.9x and P/B of 48.4x, vs. the 5Y average of 76.2x P/E and 42.6x P/B. The stock is trading at a ~2% premium to its 5Y average P/E, reflecting the market's confidence in the volume re-acceleration and the chocolate portfolio growth. The forward P/E (FY27E EPS of ₹20.4) is 69.0x, and the EV/EBITDA (FY27E) is 46.2x. The dividend yield is 0.87% (vs. 5Y average of 1.1%). The valuation is full to expensive — a 12-18 month view sees 8-12% total return in a base case, primarily driven by earnings growth rather than multiple expansion. A positive surprise on volume growth could trigger 15-20% return; a negative surprise on input costs could compress to flat or negative.

6.4 Britannia Industries — The biscuits leader, international growth story

Business. Britannia Industries is one of India's largest food companies with a 100+ year legacy and FY26 revenue of ₹19,152 cr (US$2.3 bn). The company has a dominant market position in biscuits (~36% share) and is a significant player in bread (~12% share), cakes, rusk, cheese, dairy, and beverages. The brand portfolio includes Good Day, Tiger, NutriChoice, Milk Bikis, Marie Gold, Bourbon, Treat, 50-50, Little Hearts, Pure Magic, Cheese, Top Bread, Activia (license), and others. The company has ~36% market share in biscuits (the largest in the category), competing with Parle (unlisted, ~32% share), ITC Sunfeast (~8%), Priya Gold (unlisted, ~6%), and a long tail. The promoter is the Wadia Group with a ~50.6% stake (the rest is widely held, with foreign institutional investors owning ~22%). The company operates ~30 manufacturing facilities across India and a growing international footprint in the Middle East, Africa, and SAARC.

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹4,841 cr (+8.4% YoY) with OPM of 20% and PAT of ₹655 cr (+17% YoY). Q4 FY26 (Jan-Mar 2026) revenue of ₹4,719 cr (+5.6% YoY) with OPM of 18% and PAT of ₹680 cr (+9% YoY). The full-year FY26 revenue was ₹19,152 cr (+6.7% YoY) and PAT was ₹2,537 cr (+16.5% YoY). The international business grew +18.4% YoY in FY26, contributing ~7% of revenue. The cheese and dairy portfolio grew +14% YoY, contributing ~6% of revenue. The adjacent categories (cakes, rusk, croissants) grew +12% YoY, contributing ~12% of revenue.

Margin trend. EBITDA margin has been stable in the 17-19% range over the last 5 years (FY22: 19.0%, FY23: 18.4%, FY24: 17.6%, FY25: 17.6%, FY26: 18.4%). The compression in FY24-FY25 was driven by cheese and milk input cost spikes and higher A&P spend on the dairy and rusk categories. The recovery in FY26 was driven by input cost easing (sugar, wheat, milk solids), the GST 2.0 pass-through boosting volume, and operating leverage on the dairy business. The biscuits segment EBITDA margin is in the 18-20% range, the dairy segment EBITDA margin is in the 12-15% range (sub-scale), and the international business EBITDA margin is in the 15-18% range.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration to 6-7% (vs. 3-4% in FY25), driven by the GST 2.0 anniversary base and the rural recovery; (2) International expansion — the company is investing in the Middle East (Dubai plant commissioned CY25, Saudi expansion), Africa (Egypt, Kenya), and SAARC (Nepal, Bangladesh, Sri Lanka) — the international business could be 12-15% of revenue by FY28; (3) Dairy scaling — the cheese and dairy business is at an inflection; (4) Premium portfolio (NutriChoice, Milk Bikis, Pure Magic) growing at 14-18% YoY; (5) Operating leverage on volume — each 100 bps of volume growth translates to ~50 bps of EBITDA margin expansion.

Risk. The principal risks are (1) Parle's continued competitive intensity (Parle is the most aggressive competitor on pricing, distribution, and product innovation); (2) Input cost spikes (wheat, sugar, milk, cocoa, palm oil); (3) International execution risk (the international business is sub-scale, and the Dubai and Egypt plants have execution risk); (4) Modern trade and quick commerce margin pressure (Britannia has the largest quick commerce FMCG exposure after HUL and Nestle); (5) Promoter/governance risk (the Wadia Group has been the subject of various governance issues, although Britannia's track record is clean).

Valuation vs. 5Y. Britannia trades at TTM P/E of 49.1x and P/B of 18.4x, vs. the 5Y average of 52.6x P/E and 19.2x P/B. The stock is trading at a ~7% discount to its 5Y average P/E, reflecting the market's caution on volume growth and the international execution. The forward P/E (FY27E EPS of ₹118) is 43.8x, and the EV/EBITDA (FY27E) is 29.4x. The dividend yield is 1.75% (vs. 5Y average of 1.4%). The valuation is fair to mildly attractive — a 12-18 month view sees 10-15% total return in a base case.

6.5 Dabur India — The ayurvedic, ayurveda-rooted consumer brands

Business. Dabur India is India's largest ayurvedic and natural health care company with FY26 revenue of ₹13,193 cr (US$1.6 bn). The company has a 100+ year legacy (founded 1884) and a portfolio spanning **oral care (Meswak, Red, Babool), hair oils (Vatika, Amla), chyawanprash (Dabur Chyawanprash), health supplements (Dabur Honey, Shilajit), juices (Real, Activ), baby care (Dabur Lal Tail), digestive (Pudin Hara, Hajmola), and a growing F&B portfolio (Real, premium honey, ethnic). The promoter is the Burman Family with a ~67% stake (the rest is widely held). The company operates ~12 manufacturing facilities in India, Nepal, Bangladesh, UAE, Egypt, Turkey, Nigeria, South Africa, and the US (Dabur International HQs in Dubai, with regional manufacturing). The international business contributes ~22% of revenue (FY26), with the Middle East and Africa being the largest geographies.

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹3,191 cr (-6.2% YoY) with OPM of 18% and PAT of ₹445 cr (-12% YoY). Q4 FY26 (Jan-Mar 2026) revenue of ₹3,038 cr (-3.3% YoY) with OPM of 15% and PAT of ₹362 cr (-12% YoY). The full-year FY26 revenue was ₹13,193 cr (+5.0% YoY) and PAT was ₹1,869 cr (+7.4% YoY). The Q3 and Q4 weakness was driven by the disruption in the home care personal care categories by D2C brands (especially in hair care, with mamaearth and WOW gaining share), higher A&P spend to defend share, and input cost spikes in mentha oil and packaging in early FY26.

Margin trend. EBITDA margin has been declining from the 21-22% range to the 18-19% range (FY22: 21.6%, FY23: 19.8%, FY24: 19.0%, FY25: 19.0%, FY26: 18.6%). The compression is structural, driven by (a) A&P intensity rising from 7.2% of sales in FY22 to 9.4% in FY26 (the company has been defending share against D2C), (b) premiumisation in the ayurvedic portfolio requiring higher marketing investment, (c) international business margin pressure in MENA (currency weakness, supply chain costs), and (d) subscale new categories (premium juices, ethnic foods) dragging consolidated margin.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration in the core categories (hair oils, chyawanprash, juices) — the Q4 FY26 weakness needs to reverse; (2) Premiumisation — the Odonil Naturals, Real Activ, premium honey, Vatika premium range growing at 12-15% YoY; (3) New categories — pet food, ayurvedic OTC, and functional foods (Shilajit, Ashwagandha, herbal supplements); (4) International consolidation — the company is rationalising its international portfolio (some markets are sub-scale); (5) Operating leverage on volume — each 100 bps of volume growth could translate to 30-50 bps of margin expansion.

Risk. The principal risks are (1) D2C disruption in hair care (mamaearth, WOW, Traya, mCaffeine, Be Bodywise) and oral care (Patanjali, Meswak alternatives); (2) International FX and political risk in MENA and Africa; (3) Input cost spikes in mentha oil, copra, and packaging; (4) Slowing chyawanprash category in the post-COVID base; (5) Promoter family-related-party transactions — the Burman family is the subject of ongoing regulatory and shareholder scrutiny on the holding structure and related-party deals.

Valuation vs. 5Y. Dabur trades at TTM P/E of 39.7x and P/B of 6.4x, vs. the 5Y average of 47.8x P/E and 7.6x P/B. The stock is trading at a ~17% discount to its 5Y average P/E, reflecting the market's caution on volume growth, margin compression, and D2C disruption. The forward P/E (FY27E EPS of ₹11.6) is 36.5x, and the EV/EBITDA (FY27E) is 25.6x. The dividend yield is 1.93% (vs. 5Y average of 1.6%). The valuation is fair to mildly attractive — a 12-18 month view sees 8-12% total return in a base case, with the main upside coming from a reversal of the D2C margin pressure and a rural recovery boost to chyawanprash and hair oils.

6.6 Marico — Coconut oil heavyweight, foods transition

Business. Marico is one of India's leading beauty and wellness consumer goods companies with FY26 revenue of ₹13,611 cr (US$1.6 bn) and operations in 25+ countries across Asia and Africa. The Indian business is dominated by Parachute coconut oil (58% share of branded coconut oil market), Saffola refined oils and oats (9% share of refined oils, 24% share of premium oats), Kaya skin care (D2C and clinics), Livon (serums), Set Wet (deodorants and hair styling), and a growing foods portfolio (True Elements, Z Pure, Plix, and the planned ₹1,200 cr Sanand plant). The international business (Marico International, contributing 42% of FY26 revenue) spans Bangladesh (parachute is dominant, ~50% share), Vietnam, Myanmar, MENA, and South Africa. The promoter is the Marico Family (Harsh Mariwala, Rishabh Mariwala) with a ~59% stake (Harsh Mariwala directly and through the family trust). The Bangladesh business is the single largest geographic exposure outside India, with FY26 revenue of ~₹3,800 cr.

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹3,482 cr (+27% YoY, but distorted by the acquisition of True Elements and a one-time inventory build) with OPM of 16% and PAT of ₹432 cr (-19% YoY). Q4 FY26 (Jan-Mar 2026) revenue of ₹3,333 cr (-5.6% YoY, normalising) with OPM of 16% and PAT of ₹408 cr (-11% YoY). The full-year FY26 revenue was ₹13,611 cr (+25.7% YoY, distorted by the foods acquisitions) and PAT was ₹1,813 cr (+9.3% YoY). The parachute coconut oil volumes grew +4% YoY in Q4 FY26 (vs. -3% in Q3 FY25, the inflection). The Saffola refined oils volumes grew +3% YoY in Q4 FY26. The foods business grew +62% YoY in FY26 (organic + acquired).

Margin trend. EBITDA margin has been declining from the 19-21% range to the 17-19% range (FY22: 20.4%, FY23: 19.8%, FY24: 20.2%, FY25: 19.8%, FY26: 17.1%). The compression is driven by (a) foods business drag — the acquired foods businesses (True Elements, Z Pure) and the new Sanand capex are sub-scale, (b) copra price volatility affecting parachute coconut oil margin, (c) Bangladesh FX pressure on the Taka (which has depreciated ~6% YoY against the rupee), and (d) higher A&P spend on the foods and D2C portfolio.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Parachute coconut oil volume recovery — the 4% YoY volume growth in Q4 FY26 needs to sustain; (2) Saffola premiumisation — value-added oils (olive oil, rice bran oil), oats, and ready-to-cook growing at 15-20% YoY; (3) Foods scaling — the Sanand plant (commissioning CY27) and the True Elements/Z Pure portfolio could be 8-10% of revenue by FY28; (4) Bangladesh recovery — the macro stress in Bangladesh is bottoming and the parachute business should re-accelerate; (5) Operating leverage on the foods business — the foods business EBITDA margin is currently -5% to -8%, with the path to break-even by FY28 and 5-7% by FY30.

Risk. The principal risks are (1) Foods business execution — the company is investing ₹1,200 cr in a new Sanand plant and has acquired multiple D2C brands; the integration and scale-up risk is material; (2) Copra price spikes — a bad coconut crop could compress parachute margin by 200-300 bps; (3) Bangladesh FX and political risk — Bangladesh is 30% of consolidated revenue and a Taka depreciation or political instability could compress reported growth; (4) D2C disruption in hair oils and personal care — mamaearth, WOW, mCaffeine are all in the coconut oil, hair care, and personal care categories; (5) Promoter succession — Harsh Mariwala is in his early 70s, and the succession of the family trust and the operating business is a multi-year work-in-progress.

Valuation vs. 5Y. Marico trades at TTM P/E of 60.4x and P/B of 14.6x, vs. the 5Y average of 54.2x P/E and 12.8x P/B. The stock is trading at a ~11% premium to its 5Y average P/E, reflecting the market's confidence in the parachute recovery and the foods scaling. The forward P/E (FY27E EPS of ₹15.4) is 53.2x, and the EV/EBITDA (FY27E) is 36.8x. The dividend yield is 0.49% (vs. 5Y average of 0.9%). The valuation is full — a 12-18 month view sees 6-10% total return in a base case.

6.7 Godrej Consumer Products (GODREJCP) — Home and personal care, Africa focus

Business. Godrej Consumer Products (Godrej CP) is one of India's leading FMCG companies with FY26 revenue of ₹15,178 cr (US$1.8 bn) and a portfolio spanning personal care (Cinthol, Godrej No.1, Expert, Aer, Issue), home care (Godrej Hit, Good Knight, All Out, Ezee, Protekt, Stella), and a large international business (Africa, US, Indonesia) contributing ~38% of FY26 revenue. The promoter is the Godrej Group with a ~63% stake (the rest is widely held, with foreign institutional investors owning ~22%). The company operates ~25 manufacturing facilities globally. The Africa business (Godrej Africa HQ in Durban, South Africa) is the largest geographic exposure outside India with FY26 revenue of ~₹3,200 cr and brands like Darling, Malaika, Tura, Kativa, Vignette, Mitu. The US business (acquired in 2018 with the Strength of Nature acquisition) has the Mega Strong, Soft & Beautiful, and African Pride brands, contributing ~₹1,800 cr to FY26 revenue. The Indonesia business is the leading player in the wet tissues and sanitary napkin categories.

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹3,825 cr (+6.4% YoY) with OPM of 19% and PAT of ₹459 cr (-3% YoY). Q4 FY26 (Jan-Mar 2026) revenue of ₹3,900 cr (+5.6% YoY) with OPM of 22% and PAT of ₹452 cr (-4% YoY). The full-year FY26 revenue was ₹15,178 cr (+5.7% YoY) and PAT was ₹1,861 cr (+0.5% YoY). The Indian business grew +4.2% YoY in FY26, the Africa business grew +4.8% YoY in constant currency, the US business grew +5.6% YoY in constant currency, and the Indonesia business grew +8.4% YoY in constant currency. The consolidated EBITDA margin improved from 20.6% in FY22 to 20.8% in FY26, despite the A&P intensity rising from 8.4% to 10.2% of sales.

Margin trend. EBITDA margin has been stable in the 20-22% range over the last 5 years (FY22: 22.0%, FY23: 20.6%, FY24: 21.0%, FY25: 21.0%, FY26: 20.8%). The Indian personal care segment EBITDA margin is in the 20-24% range, the Indian home care segment EBITDA margin is in the 18-22% range, the Africa business EBITDA margin is in the 15-18% range, and the US business EBITDA margin is in the 10-12% range (sub-scale post the acquisition). The consolidated ROCE is at 19.1% in FY26, down from 27% in FY22, reflecting the international acquisitions dragging the consolidated metric.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration in India to 6-7% (vs. 3-4% in FY25), driven by rural recovery and the GST 2.0 boost; (2) Africa and US scale-up — the company is investing in distribution expansion in Africa and brand investment in the US to grow the international business from 38% to 42% of revenue by FY28; (3) Personal care premiumisation — the new Cinthol and Aer premium launches growing at 12-15% YoY; (4) Home care innovation — the new Godrej Protekt, Ezee Liquid, and Stella machine launches; (5) Operating leverage on volume — each 100 bps of volume growth could translate to 30-50 bps of margin expansion.

Risk. The principal risks are (1) Africa FX and political risk — Nigeria, Kenya, and South Africa have material currency volatility (the Naira depreciated 38% in FY24, the Kenyan Shilling 21%); (2) US business sub-scale and low-margin — the Strength of Nature acquisition is still in turnaround mode; (3) A&P intensity rising without commensurate volume response; (4) Indonesia and Asian business competition from the local incumbents; (5) Related-party transactions with the Godrej Group (the Group has other consumer-facing businesses, e.g., Godrej Appliances, Godrej Agrovet, Godrej Properties) — the SEBI's tightening on related-party transactions is a structural watchpoint.

Valuation vs. 5Y. Godrej CP trades at TTM P/E of 52.1x and P/B of 7.6x, vs. the 5Y average of 56.4x P/E and 8.4x P/B. The stock is trading at an ~8% discount to its 5Y average P/E, reflecting the market's caution on Africa FX, A&P intensity, and the international business. The forward P/E (FY27E EPS of ₹20.4) is 46.4x, and the EV/EBITDA (FY27E) is 30.4x. The dividend yield is 1.94% (vs. 5Y average of 0.7% — the dividend payout stepped up materially in FY25-FY26). The valuation is fair to mildly attractive — a 12-18 month view sees 10-14% total return in a base case.

6.8 Colgate-Palmolive (India) (COLPAL) — The oral care compounder, narrow moat

Business. Colgate-Palmolive (India) is the largest toothpaste and toothbrush company in India with FY26 revenue of ₹1,960 cr (US$0.24 bn, the smallest in the Nifty FMCG universe by revenue). The company operates in a single sub-vertical — oral care — with a portfolio spanning Colgate Strong Teeth, Colgate Total, Colgate Visible White, Colgate Optic White, Colgate MaxFresh, Colgate SlimSoft, Colgate Cibaca, Colgate Sensitive Pro-Relief, Palmolive (body wash), and Axion (dishwash, distributed). The Colgate brand has a ~52% market share in toothpaste (per NielsenIQ data) and a ~42% market share in toothbrushes, the dominant position in the category. The promoter is Colgate-Palmolive Company (USA) with a ~51% stake (the rest is widely held). The company operates 2 manufacturing facilities in India (Aurangabad and Sanand). The distribution reach is ~5 million retail outlets.

Q3/Q4 FY26. The Q3 and Q4 FY26 quarterly data is not separately reported on screener.in for Colpal in a way that is comparable to other names (the screener has only annual and 5-year data for Colpal, reflecting the company's smaller disclosure footprint). Based on the company's investor presentations: Q3 FY26 (Oct-Dec 2025) revenue of ₹520 cr (+5.2% YoY) with OPM of 23% and PAT of ₹118 cr (+12% YoY). Q4 FY26 (Jan-Mar 2026) revenue of ₹508 cr (+4.6% YoY) with OPM of 22% and PAT of ₹109 cr (+9% YoY). The full-year FY26 revenue was ₹1,960 cr (+6.4% YoY) and PAT was ₹436 cr (+19.4% YoY). The toothpaste volume growth was +4.2% YoY in Q4 FY26 (the highest in 5 years), driven by the rural recovery and the new Colgate Visible White launches.

Margin trend. EBITDA margin has been expanding materially from the 17-19% range to the 22-24% range (FY22: 19.4%, FY23: 19.2%, FY24: 19.0%, FY25: 21.4%, FY26: 22.1%). The expansion is driven by (a) premiumisation — Colgate Visible White, Optic White, Total, and Sensitive Pro-Relief now contribute ~38% of revenue (vs. 22% in FY22), and premium SKUs carry 200-300 bps higher gross margin, (b) input cost tailwind — the calcium carbonate, sorbitol, fluoride, and packaging inputs are all at multi-year lows, (c) operating leverage on volume growth, and (d) lower A&P intensity — A&P spend has come down from 14% of sales in FY22 to 9.6% in FY26, reflecting the company's "less mass-media, more digital" strategy.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration to 4-5% (vs. 2-3% in FY25), driven by rural recovery and the new launches; (2) Premium portfolio scaling — Visible White, Optic White, and Sensitive Pro-Relief growing at 18-22% YoY; (3) Adjacent categories — the company is investing in mouthwash, electric toothbrushes (via the Colgate Hum and Colgate ProClinical brands), and whitening strips; (4) Modern trade and quick commerce — the company is the largest oral care supplier on quick commerce, with 12-15% of revenue from this channel; (5) Operating leverage on volume — each 100 bps of volume growth could translate to 50-70 bps of margin expansion.

Risk. The principal risks are (1) Dabur Meswak and Patanjali Dant Kanti gaining share in the herbal/natural toothpaste category; (2) HUL Close-Up and Pepsodent competitive intensity in the mid-tier; (3) D2C disruptors in oral care (Perfora, Dabur Red, Ayush, Meswak); (4) Input cost spikes in calcium carbonate, sorbitol, and packaging; (5) Parent capital allocation — Colgate-Palmolive USA's global strategy of "premium and emerging markets" is supportive, but any strategic shift could affect the India subsidiary.

Valuation vs. 5Y. Colpal trades at TTM P/E of 131x and P/B of 38.6x, vs. the 5Y average of 108x P/E and 32.4x P/B. The stock is trading at a ~21% premium to its 5Y average P/E, reflecting the market's confidence in the margin expansion story. The forward P/E (FY27E EPS of ₹18.4) is 112x, and the EV/EBITDA (FY27E) is 68x. The dividend yield is 2.45% (vs. 5Y average of 1.8%). The valuation is full to expensive — a 12-18 month view sees 5-10% total return in a base case, primarily from earnings growth, with limited multiple expansion potential.

Note: The screener.in data for Colpal shows the most recent year (FY26) at ₹1,960 cr, which is the FY26 standalone figure, while prior years (FY22-FY25) include both consolidated and standalone figures that are not directly comparable due to a change in the reporting structure. The growth rate and margins are calculated by NiftyBrief on a like-for-like basis where possible.

6.9 Tata Consumer Products (TATACONSUM) — The Tata Group's branded foods play

Business. Tata Consumer Products is the Tata Group's branded foods and beverages platform with FY26 revenue of ₹20,290 cr (US$2.4 bn), the third-largest pure-play foods company in India (after ITC Foods and Britannia). The company was rebranded from Tata Global Beverages in February 2020 and has since executed a transformative M&A-led growth strategy, acquiring Capital Foods (Ching's, Smith & Jones) in CY23, Organic India in CY22, Kanan Devan (tea) consolidation, and most recently the Stellar Health (Soulfull Ragi-based foods) and Haldiram's snacks (Tata's stake increase) deals. The portfolio spans Tata Tea (India and UK), Tata Coffee, Tata Salt (33% share of branded salt), Tata Sampann (pulses, spices, besan, poha), Eight O'Clock Coffee (US), Tata Cha (cafe chain), Capital Foods (Ching's sauces, Smith & Jones), Organic India (wellness), and a long tail. The promoter is the Tata Group with a ~46% stake (the rest is widely held). The international business contributes ~28% of revenue (FY26), with the US (Eight O'Clock), UK (Tata Tea), and Canada (Tata Tea) being the largest.

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹4,966 cr (+9.2% YoY) with OPM of 14% and PAT of ₹385 cr (-19% YoY, normalised for a one-time Q3 FY25 base). Q4 FY26 (Jan-Mar 2026) revenue of ₹5,434 cr (+9.4% YoY) with OPM of 15% and PAT of ₹424 cr (-2% YoY, normalised). The full-year FY26 revenue was ₹20,290 cr (+15.1% YoY, the highest growth in the Nifty FMCG universe) and PAT was ₹1,547 cr (+20.2% YoY). The organic growth in the core business (excluding acquisitions) was +9.4% YoY, and the acquisition contribution (Capital Foods, Organic India, Stellar Health) was ~5.7% YoY. The Tata Salt volumes grew +4.2% YoY in Q4 FY26, the Tata Tea volumes grew +2.4% YoY, the Capital Foods (Ching's) revenue grew +22% YoY, and the US coffee (Eight O'Clock) revenue grew +6% YoY in constant currency.

Margin trend. EBITDA margin has been stable in the 13-15% range over the last 5 years (FY22: 12.4%, FY23: 13.4%, FY24: 13.8%, FY25: 13.8%, FY26: 13.8%). The tea segment EBITDA margin is in the 12-15% range (commodity-linked, moderate pricing power), the salt segment EBITDA margin is in the 22-26% range (high gross margin, high ROCE), the coffee segment EBITDA margin is in the 8-12% range (commodity-linked), and the Capital Foods (Ching's) EBITDA margin is in the 18-22% range (mid-teens branded). The consolidated EBITDA margin is dragged by the international tea business (Tata Tea UK, US) and the coffee business, both of which are commodity-linked with limited margin expansion.

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration to 5-6% (vs. 3-4% in FY25), driven by rural recovery and the GST 2.0 boost on Tata Salt and Tata Sampann; (2) Capital Foods scaling — Ching's sauces, Smith & Jones, and the soulfull ragi foods are growing at 18-22% YoY, and the integration is on track; (3) US coffee (Eight O'Clock) and UK tea (Tata Tea) recovery — both are benefiting from the post-COVID premium tea/coffee cycle; (4) New categories — the company is investing in protein supplements (Tata GoFit, Tata Simply Better), RTD beverages (Tata Tea Cold, Tata Coffee Cold), and aqua (Tata Water, recently launched in select markets); (5) Operating leverage on the M&A portfolio — the acquired businesses are sub-scale at the EBITDA line and have the path to consolidated margin expansion.

Risk. The principal risks are (1) M&A integration risk — the Capital Foods, Organic India, and Stellar Health deals are still in integration; (2) International tea and coffee commodity exposure — Tata Tea UK and Eight O'Clock US are exposed to tea and coffee commodity cycles; (3) Salt regulatory risk — the FSSAI tightening on salt iodine content and the iodised vs. non-iodised debate; (4) Competition from Brooke Bond (HUL) in the tea category; (5) Tata Sons cross-holding — the Tata Sons stake in Tata Consumer Products is at ~46%, and any further consolidation (e.g., the speculated Starbucks India, Haldiram's full integration) is subject to Tata Group cross-holding dynamics.

Valuation vs. 5Y. Tata Consumer trades at TTM P/E of 70.9x and P/B of 5.6x, vs. the 5Y average of 58.4x P/E and 4.2x P/B. The stock is trading at a ~21% premium to its 5Y average P/E, reflecting the market's confidence in the M&A-led growth strategy and the international turnaround. The forward P/E (FY27E EPS of ₹17.6) is 62.8x, and the EV/EBITDA (FY27E) is 35.2x. The dividend yield is 0.91% (vs. 5Y average of 0.7%). The valuation is full to expensive — a 12-18 month view sees 8-12% total return in a base case.

6.10 Emami — The cool oil and balm specialist, distribution turnaround story

Business. Emami is one of India's leading personal care and healthcare companies with FY26 revenue of ₹3,780 cr (US$0.46 bn), the smallest company in the Nifty FMCG universe by revenue. The company has a ~50 year legacy (founded 1974) and a portfolio spanning cool oils (Navratna, ~22% share of branded cool oil market), ayurvedic and OTC (Zandu Balm, ~36% share, Zandu Pancharishta, Zandu Kesari Jivan, Zandu Chyawanprash), pain management (Fast Relief, Tiger Balm competing), beauty (Fair and Handsome, ~32% share of men's fairness cream, BoroPlus), and Kesh King (hair care). The promoter is the Agarwal Family with a ~53% stake (the rest is widely held). The company operates ~9 manufacturing facilities in India. The distribution reach is ~4 million retail outlets. The international business contributes ~18% of revenue (FY26), with the Middle East, SAARC, and Africa being the largest geographies.

Q3/Q4 FY26. Q3 FY26 (Oct-Dec 2025) revenue of ₹799 cr (-12% YoY, distorted by the seasonal Q3 vs. Q4 mix) with OPM of 22% and PAT of ₹148 cr (-10% YoY). Q4 FY26 (Jan-Mar 2026) revenue of ₹925 cr (-19% YoY, weak Q4 print) with OPM of 20% and PAT of ₹143 cr (-32% YoY). The full-year FY26 revenue was ₹3,780 cr (-0.8% YoY) and PAT was ₹775 cr (-3.5% YoY). The Q4 weakness was driven by (a) distribution slippage in the modern trade and quick commerce channels, (b) Kesh King underperformance (the brand was acquired in 2015 for ₹1,650 cr and is still sub-scale), (c) higher A&P spend in a bid to defend share, and (d) rural weakness in the Hindi-speaking heartland markets (UP, Bihar, MP, Rajasthan).

Margin trend. EBITDA margin has been declining from the 28-30% range to the 24-26% range (FY22: 30.2%, FY23: 28.4%, FY24: 27.0%, FY25: 26.6%, FY26: 25.4%). The compression is driven by (a) higher A&P spend rising from 12% of sales in FY22 to 16.4% in FY26, (b) Kesh King underperformance dragging consolidated margin, (c) input cost spikes in mentha oil, packaging, and glass in H1 FY26, and (d) subscale new categories (Fair and Handsome modern, BoroPlus premium). The Zandu portfolio is the most profitable segment (EBITDA margin 32-36%) while the Kesh King portfolio is the least profitable (EBITDA margin 8-12%).

Growth driver. The FY27 growth case rests on 5 vectors: (1) Volume re-acceleration in the core cool oil and balm categories, driven by the rural recovery and the GST 2.0 boost; (2) Kesh King turnaround — the company is rationalising the brand's distribution and investing in marketing to re-establish growth; (3) Zandu premiumisation — the Zandu Kesari Jivan premium, Zandu Pancharishta premium, and Zandu Chyawanprash growing at 10-12% YoY; (4) New categories — the company is investing in sexual wellness (Emami had acquired a stake in the He-She range), ayurvedic OTC, and D2C; (5) Distribution turnaround — the company is investing ₹80-100 cr in modern trade and quick commerce distribution, which is the segment of FMCG growth.

Risk. The principal risks are (1) Distribution slippage — the company has lost shelf space in modern trade and quick commerce in CY25; (2) Kesh King brand underperformance — the brand has been sub-scale for years; (3) D2C disruption in cool oils and balms — mamaearth, WOW, mCaffeine, and a long tail of D2C brands are entering the ayurvedic and natural personal care categories; (4) Mentha oil price spikes — a bad mentha crop could compress margin by 200-300 bps; (5) Promoter family-related-party transactions — the Agarwal family has multiple related-party dealings (real estate, agri, packaging) that the SEBI has been scrutinising.

Valuation vs. 5Y. Emami trades at TTM P/E of 21.8x and P/B of 4.6x, vs. the 5Y average of 34.2x P/E and 6.4x P/B. The stock is trading at a ~36% discount to its 5Y average P/E, the largest discount in the Nifty FMCG universe, reflecting the market's caution on volume growth, distribution, and Kesh King. The forward P/E (FY27E EPS of ₹18.6) is 20.4x, and the EV/EBITDA (FY27E) is 13.6x. The dividend yield is 2.56% (vs. 5Y average of 1.6%). The valuation is attractive but the turnaround thesis is not yet proven — a 12-18 month view sees 12-18% total return in a base case (turnaround delivers) and flat to negative in a bear case (turnaround stalls).

6.11 Cross-stock comparison — Top 10 dashboard

Note: Negative public holding indicates the FII + DII + Promoter totals exceed 100% (likely due to cross-holdings or classification differences).

6.12 Q3 + Q4 FY26 quarterly trajectory — quarter by quarter

Note: ITC Q1 FY26 PAT of ₹19,808 cr includes the one-time gain on the hotels demerger. HUL Q4 FY26 PAT of ₹6,603 cr includes a one-time Other Income and tax benefit. The Q1 FY27 (est) is the NiftyBrief estimate based on management commentary, channel checks, and macro assumptions.

The quarterly trajectory shows the inflection in Q3-Q4 FY26 for most names — underlying volume growth re-accelerated, the GST 2.0 pass-through boosted gross margin, and the rural recovery became visible in the channel data. The Q4 FY26 print was the best quarter for the universe in 6 quarters, with 8 of 10 names reporting YoY PAT growth.

7. Valuation Framework

The valuation framework for the Nifty FMCG universe must grapple with three distinct sub-questions: (1) how does the sector trade vs. its 5-year history (relative-to-history), (2) how does it trade vs. the broader Nifty 50 (relative-to-market), and (3) how does it trade vs. global FMCG peers (relative-to-global). The framework also needs a DCF analysis for one anchor name to ground the multiples in fundamental cash flow. We do all three in this section.

7.1 Sector P/E, P/B, EV/EBITDA vs. 5Y average

Source: NSE, BSE, company filings, NiftyBrief compilation as on 13 June 2026. P/E and P/B are trailing twelve months.

The valuation context is clear: the Nifty FMCG index is trading at an 8-17% discount to its 5-year average on every metric, while the Nifty 50 is trading at a 3-11% premium to its 5-year average. The FMCG-vs-Nifty premium has compressed to 1.82x P/E (vs. 5Y avg of 2.04x) and 2.55x P/B (vs. 5Y avg of 3.22x). The dividend yield spread between FMCG and the broader Nifty has widened to 90 bps (vs. 5Y avg of 68 bps), the widest in 7 years (since the COVID-era 100 bps in March 2020).

This is the central valuation argument of this report. The Nifty FMCG index has de-rated relative to its own history and relative to the broader market, despite the sector delivering stable ROCE (38% vs. 5Y avg 39%), stable dividend payout (78% vs. 5Y avg 80%), and stable free cash flow generation. The re-rating case is simple: if the volume comeback delivers as expected in FY27, the Nifty FMCG P/E should expand back to the 5Y mean of 44.8x — a 8.7% multiple expansion that, combined with 8-10% earnings growth, would deliver 17-19% total return on a 12-18 month view.

7.2 Stock-by-stock valuation vs. 5Y and vs. sector

Stocks trading at meaningful discount to 5Y average (potential re-rating plays): ITC (-16.2%), Dabur (-17.0%), Emami (-36.3%), HUL (-12.8%), and Godrej CP (-7.6%).

Stocks trading at meaningful premium to 5Y average (potential de-rating risk): Tata Consumer (+21.4%), Colgate (+21.3%), and Marico (+11.4%).

Stocks trading near 5Y average (fair value): Nestle India (+2.2%) and Britannia (-6.7%).

7.3 Nifty FMCG vs. global FMCG peers

Source: Bloomberg consensus, company filings, NiftyBrief compilation as on 13 June 2026. P/E and P/B trailing 12 months.

The Nifty FMCG trades at a meaningful premium to global FMCG peers — at 41.2x P/E vs. the global average of 18-22x. This premium is justified by:

• Higher growth — 8.4% revenue CAGR vs. global 1.5-5%
• Higher margin trajectory — Indian FMCG has margin expansion potential from premiumisation
• Demographic tailwind — median age 28.4 vs. 38-44 for developed markets
• Currency tailwind — Indian rupee has averaged 3-4% annual depreciation
• Consumption penetration — per-capita FMCG spend at $78 vs. $300-700 for developed markets

The premium is not justified vs. L'Oreal (32.4x P/E, 8.2% revenue CAGR) and Lotte (similar premium, similar growth). The premium is comparable to Unilever Indonesia's HMB (28-30x P/E) and Indonesian cigarette company HM Sampoerna (16-18x P/E). The premium is wide vs. Unilever plc (16.8x P/E, 1.6% growth), but that reflects the parent-vs-subsidiary dichotomy (Indian subsidiaries always trade at premium to MNC parents due to higher growth and lower multiple compression in the Indian context).

7.4 DCF for an anchor name — Hindustan Unilever

To ground the multiples in fundamental cash flow, we run a 10-year DCF for Hindustan Unilever as the anchor name. The DCF uses the following assumptions:

Revenue growth assumption: FY27: +8%, FY28: +9%, FY29: +10%, FY30: +9%, FY31: +8%, FY32: +8%, FY33: +7%, FY34: +7%, FY35: +6%, FY36: +6%. This implies a ~7.8% revenue CAGR over 10 years, consistent with the volume re-acceleration, premiumisation, and new category tailwinds.

EBITDA margin assumption: FY27: 23.8%, FY28: 24.4%, FY29: 24.8%, FY30: 25.0%, FY31: 25.2%, FY32: 25.3%, FY33: 25.3%, FY34: 25.2%, FY35: 25.2%, FY36: 25.0%. This implies ~25% steady-state EBITDA margin, consistent with the gross margin tailwind and operating leverage on premiumisation.

DCF interpretation. The DCF-derived fair value of ₹1,194/share is 44.7% below the current market price of ₹2,144. The DCF says HUL is expensive on intrinsic value. However, the DCF is anchored in a 6.5% terminal growth rate and a 9.8% WACC — both of which are conservative. Sensitivity analysis:

• Bull case (WACC 8.5%, terminal growth 7.5%): fair value ₹1,690, still 21% below current
• Base case (WACC 9.8%, terminal growth 6.5%): fair value ₹1,194, 44% below current
• Bear case (WACC 11.0%, terminal growth 5.5%): fair value ₹880, 59% below current

The DCF suggests the market is pricing HUL at a meaningful premium to intrinsic value, reflecting (a) the brand-compounding premium that HUL commands, (b) the scarcity value of the largest FMCG franchise in India, and (c) the structural defensive-cash-flow characteristics that drive a higher terminal multiple than the WACC-implied. The 12-month target of ₹2,360 (10% upside) is consistent with the multiple-anchored forward P/E of 35x FY27E EPS of ₹68 and the historical FMCG-vs-Nifty 50 premium, not the DCF.

7.5 Implied multiples for the universe

Source: NiftyBrief estimates based on volume comeback, input cost tailwind, GST 2.0 pass-through, and management guidance. Implied 12-mo return is based on a 12-month price target using forward P/E of 35x for HUL, 18x for ITC, 65x for Nestle, 45x for Britannia, 38x for Dabur, 55x for Marico, 48x for Godrej CP, 120x for Colpal, 65x for Tata Consumer, 22x for Emami — these are the midpoints of the 5Y P/E ranges. The "Mkt Price" column reflects approximate 13-Jun-2026 closing prices.

7.6 The relative-value framework

The Nifty FMCG index at 41.2x TTM P/E is at the lower end of its 5Y P/E range (38-50x) and trades at a 1.82x premium to the Nifty 50 (vs. the 5Y average of 2.04x). The combination of:

• FMCG absolute de-rating of -8% from 5Y average P/E
• Nifty 50 absolute re-rating of +3% from 5Y average P/E
• FMCG-vs-Nifty premium compression of -11% from 5Y average

...creates a structural relative-value setup that has not been seen since the COVID-era trough of March 2020. The base case in this report is that the Nifty FMCG index re-rates back to the 5Y average P/E of 44.8x over the next 12-18 months, delivering an 8.7% multiple expansion in addition to 8-10% earnings growth, for a 17-19% total return on the index level.

8. FII/DII Flows & Institutional Positioning

The institutional ownership and flow profile of the Nifty FMCG universe is structurally different from the broader market in three important ways. First, the FII holding of the FMCG universe is much higher than the Nifty 50 average, reflecting the global FMCG benchmark inclusion. Second, the DII holding is also much higher, reflecting the sector's inclusion in domestic mutual fund core portfolios. Third, the promoter holding is high for the family-owned names (HUL, Dabur, Marico, Godrej CP, Colgate) and zero for ITC, making the free-float adjusted weights the appropriate measure of investible market cap.

8.1 Shareholding pattern (as on March 31, 2026)

Source: BSE shareholding pattern filings for Q4 FY26 (March 31, 2026). Weighted by free-float market cap. Negative public holding indicates classification differences (FII + DII + Promoter totals > 100%).

ITC is the most widely-held FMCG stock with zero promoter holding and 41.8% FII + 27.4% DII = 69.2% institutional holding. This makes ITC the most flow-sensitive name in the universe. Colgate and Emami are the least institutionally held (21.0% and 17.0% respectively), making them the most family-controlled and least flow-sensitive.

8.2 FII flow history (CY21 - CY26 YTD)

Source: NSDL, BSE, NSE, NiftyBrief compilation. FII flows in equity cash market, net of secondary market sales.

The FII flow trajectory shows a clear pattern: CY21 was the peak of FII interest in FMCG (the post-COVID defensive trade), CY22-CY25 was a period of FII underweight in FMCG (the global rate-hike cycle diverted flows to US tech and cyclicals), and CY26 YTD has seen a modest re-entry into FMCG (the rate-easing cycle, the relative-value setup, and the volume comeback thesis). The FII underweight in FMCG is at the deepest in 7 years (per a Morgan Stanley India Strategy report from May 2026), and any reversal of this underweight could be a meaningful tailwind for the index.

8.3 DII flow history (CY21 - CY26 YTD)

Source: AMFI, NSE, BSE, NiftyBrief compilation. Net equity flow across all mutual fund schemes.

The DII flow trajectory is the mirror image of the FII flow: DIIs have been net buyers of FMCG every year for the last 6 years, providing a structural floor under the index. The MF holding in Nifty FMCG has risen from ~9.4% in CY21 to ~14.8% in CY26 YTD, with the DII share of total FMCG free-float rising from ~12% to ~18% over the same period. The DII-vs-FII flow reversal is the key institutional positioning story of the last 3 years.

8.4 Top 5 mutual fund holdings in the FMCG universe

Per AMFI's May 2026 disclosures, the top 5 mutual funds with the largest FMCG exposure are:

The FII ownership of Nifty FMCG is at 24.6% (free-float adjusted), vs. the Nifty 50 average of 21.8%, and the DII ownership is at 18.4% vs. the Nifty 50 average of 15.6%. The combined institutional ownership of the FMCG universe (43.0%) is meaningfully higher than the Nifty 50 average (37.4%), reflecting the structural defensive-cash-flow characteristics that make FMCG a core portfolio holding for both FII and DII mandates.

8.5 Institutional positioning in FY26 — flow data and positioning survey

Source: NSDL, BSE, NSE, AMFI, IRDA, PFRDA, NiftyBrief compilation.

FY26 was a net-positive year for institutional flows into FMCG (₹20,200 cr combined, vs. ₹4,000 cr in FY25 and -₹2,000 cr in FY24), driven by the FII reversal in H2 FY26 (post the RBI rate cuts and the volume comeback data) and the continued DII buying (mutual funds, insurance, pension). The Q4 FY26 print of ₹9,200 cr net institutional buying was the highest quarterly institutional flow into FMCG in 5 years and reflects the market's recognition of the FY27 setup.

8.6 The FII underweight and its potential reversal

The FII positioning survey data (per a Morgan Stanley India Strategy report from May 2026) shows that FIIs are underweight India FMCG by 220 bps relative to the MSCI India benchmark weight, the deepest underweight since the 2017 GST transition. The MSCI India FMCG weight is 5.4% of the MSCI India index, and FIIs are at 3.2% effective weight, the gap of 220 bps being the largest in 9 years. A reversal of this underweight (FIIs returning to a neutral weight) would imply ~$2.4 billion of incremental FII flow into Indian FMCG over a 12-18 month period, which is a ~12% of free-float market cap incremental demand — a meaningful re-rating catalyst.

The MSCI EM Consumer Staples index has a 6.4% weight for India (the largest single country in the index, reflecting the size of HUL, ITC, Nestle, and the other names), and the MSCI India FMCG free-float has 14 of 17 EM passive flows as buyers. The FII flow into Indian FMCG has a 3.4x multiplier from the global EM passive flows and a 1.8x multiplier from the FII active flows, based on a CLSA India Strategy report from May 2026.

8.7 Promoter holding changes (CY25-CY26 YTD)

Promoter holding has been stable across the universe, with no major divestments or buybacks. The free-float adjusted weights have remained essentially constant, and the MSCI / NSE rebalancing flows have been the main driver of institutional flows.

9. Earnings Cycle Analysis

The earnings cycle analysis for the Nifty FMCG universe in FY26 reflects three narratives: (1) Q3 FY26 was the inflection quarter for volume growth across the universe, (2) Q4 FY26 was the strongest quarter in 6 quarters for revenue and PAT growth, and (3) management commentary across the universe has shifted from "cautious" to "cautiously optimistic" on FY27. The base case for FY27 is a return to mid-to-high single-digit underlying volume growth for the universe, driven by rural recovery, the GST 2.0 anniversary base, and the input cost tailwind.

9.1 FY26 quarterly beat/miss by company

Source: Bloomberg consensus estimates pre-earnings, NiftyBrief analysis. Beat/Miss measured on reported PAT vs. consensus.

The beat rate has improved from 1/10 in Q1 FY26 to 5/10 in Q4 FY26, a clear inflection. The strongest Q4 FY26 was Nestle India (record quarterly revenue and PAT), Britannia (record quarterly revenue), and HUL (ex-one-time). The weakest Q4 FY26 was Emami (-10% miss), Marico (-6% miss), and Dabur (-4% miss) — all in the personal care / non-foods space.

9.2 Management commentary — FY27 outlook

The management commentary from the Q4 FY26 earnings calls has shifted decisively to a more positive FY27 outlook, with the following key points:

The management commentary shows a clear bifurcation: the foods players (Nestle, Britannia, Tata Consumer, ITC Foods) and the mass personal care with strong distribution (HUL, Colgate) are guiding to mid-to-high single-digit volume growth and margin expansion in FY27, while the challenged personal care (Dabur, Marico, Emami) are guiding to more cautious numbers and continued A&P intensity. The agricultural / commodity-linked personal care (Dabur, Marico, Emami) are also exposed to mentha oil, copra, and packaging cost volatility.

9.3 Q3 FY26 detailed earnings — beat/miss by sub-vertical

The sub-vertical beat rate shows the foods and beverages bucket has been the most consistent in beating, with 5/6 names beating in Q3 and 6/6 in Q4. The personal care bucket is more challenged, with 3/7 beating in Q3 and 4/7 in Q4. The home care bucket is solidly in the middle. The tobacco and cigarettes bucket has been pricing-driven, with the 4-6% MRP-led growth offsetting the 1-2% volume decline.

9.4 FY27 consensus expectations (broker survey)

A survey of 18 sell-side analysts (NiftyBrief compilation, May 2026) for FY27 estimates:

Source: Bloomberg, Refinitiv, NiftyBrief compilation. Median of 18 sell-side analysts as of May 2026.

The consensus is for 8% revenue growth and 9.4% PAT growth for the Nifty FMCG universe in FY27, materially above the FY24-FY25 average of 6% revenue growth and 4% PAT growth. The most upgraded names are Tata Consumer (M&A-led growth), Marico (parachute recovery + foods scaling), and Britannia (international expansion + dairy scaling). The least upgraded are Emami (turnaround not yet visible), Dabur (D2C margin pressure), and Colgate (premium portfolio at saturation).

9.5 Earnings revision trajectory (last 6 months)

The earnings revision trajectory is the single most important forward indicator of where the sector is heading. The FY27 EPS estimate has been revised up by +1.6% for the sector over the last 6 months, with 5 names seeing upgrades (HUL, Nestle, Britannia, Marico, Tata Consumer) and 2 names seeing downgrades (Dabur, Emami). The upgrades are concentrated in foods and premium personal care, while the downgrades are in the mass personal care under D2C pressure.

9.6 The Q3 FY26 inflection — what changed

The Q3 FY26 quarter (Oct-Dec 2025) was the inflection quarter for the sector. Three things changed:

• Volume growth re-accelerated — HUL went from 1% in H1 to 5% in Q4; ITC FMCG-Others went from 4% in H1 to 6% in Q3-Q4; Marico parachute went from -3% in Q3 FY25 to +4% in Q4 FY26
• The GST 2.0 pass-through stabilised — the price reductions taken in October-November 2025 anniversary-ed, and the gross margin benefit started to flow through
• The input cost cycle turned definitively — palm oil, copra, mentha oil, and crude were all at multi-year lows in November 2025-January 2026

The Q3 FY26 earnings call transcripts (HUL, Nestle, Britannia, Godrej, Colgate, Tata Consumer) all highlighted the "demand momentum, particularly in rural India, the price-volume mix stability post the GST transition, and the operating leverage from input cost tailwind" as the three pillars of the FY27 setup.

The Q4 FY26 print was the strongest quarter in 6 quarters for the universe, with:

• 5/10 names beat consensus on PAT
• 7/10 names delivered YoY PAT growth
• 3/10 names delivered double-digit YoY PAT growth
• The sector aggregate revenue grew 6.4% YoY and PAT grew 4.8% YoY (normalised for one-time items), the highest in 6 quarters

The FY27 setup is now a function of:

• Sustaining the volume momentum — the Q3-Q4 FY26 prints need to continue through Q1-Q2 FY27
• The input cost tailwind flowing through to gross margin — already visible in Q3-Q4 FY26, needs to continue
• The rural recovery becoming more broad-based — the Q4 FY26 rural data was promising, but the distribution and credit data for Q1 FY27 (post the rabi harvest and the monsoon onset) will be the next inflection

10. Risks & Catalysts Matrix

This section lays out the 10 principal risks and the 5 principal catalysts for the Nifty FMCG universe over the next 12-18 months, with a probability × impact grid.

10.1 Risks — Probability × Impact matrix

10.2 Catalysts — Probability × Impact matrix

10.3 Net risk-reward

The net risk-reward of the Nifty FMCG universe is decidedly positive for a 12-18 month view. The expected value of the risks is -260 bps (probability-weighted), the expected value of the catalysts is +475 bps (probability-weighted), and the net expected value is +215 bps. In other words, the risk-reward is approximately 1.8:1 in favour of the bulls, with the upside skewed by the multiple expansion catalyst (probability 60%, impact 800-1,000 bps) and the downside contained by the limited downside scenarios (most of the risks are in the 100-400 bps range, not 500+ bps).

10.4 Key data points to watch

The single most important data point is the NielsenIQ FMCG volume growth (quarterly). The Q1 FY27 print (data for Apr-Jun 2026) is due in mid-July 2026 and will be the first read on whether the Q3-Q4 FY26 momentum has continued. A print of >7% YoY would be a decisive bullish signal; a print of <3% YoY would be a decisive bearish signal.

10.5 Tail risks — the left tail

The tail risks are real but low-probability. The composite probability of a 800+ bps downside scenario is ~5-7%, vs. the composite probability of a 800+ bps upside scenario of ~25-30%. The expected value of the tail is strongly positive.

11. Outlook & Actionable Conclusions

This section synthesises the analytical findings of the prior 10 sections into an outlook and actionable conclusion. The structure: (1) the 12-month sector call, (2) the top 3 picks, (3) the top 3 avoids, (4) the 5 things to watch, (5) the closing view.

11.1 12-month sector call — Overweight (with conditions)

The Nifty FMCG sector is rated Overweight for a 12-month horizon, with a base case 12-month price target of 62,500-65,000 for the index (currently at 54,820, implying 14-19% upside), plus a 2.3% dividend yield, for a 16-21% total return in a base case. The Overweight call is anchored in five interlocking arguments:

Argument 1 — The volume comeback is real and will sustain. The Q3-Q4 FY26 prints show volume growth re-accelerating across the universe (HUL 5%, ITC FMCG-Others 6%, Marico parachute 4%, Colgate toothpaste 4%, Tata Consumer Ching's 22%). The rural recovery is visible in the NielsenIQ data (rural growth 8.2% YoY in CY25 vs. urban 6.1%), the 2-wheeler sales (+12.4% YoY in FY26), and the tractor sales (+8.2% YoY). The Q1 FY27 print (due mid-July 2026) is the next critical data point.

Argument 2 — The input cost tailwind is durable. The composite FMCG input basket is down -6.8% YoY in FY26 and forecast to be down another -3.4% YoY in FY27. Crude at $68-72/bbl, palm oil at MYR 3,850-4,100/MT, copra at ₹11,200-12,000/quintal, mentha oil at ₹1,150-1,250/kg — every major input is at a 2-4 year low. The gross margin tailwind of 50-120 bps is the second pillar of the FY27 setup.

Argument 3 — The valuation is at -8% to -17% discount to 5-year average across metrics. The Nifty FMCG trades at 41.2x TTM P/E vs. 5Y average 44.8x (-8.0%), 10.2x P/B vs. 11.6x (-12.1%), 28.4x EV/EBITDA vs. 30.4x (-6.6%). The re-rating to 5Y average is the third pillar — a simple mean-reversion.

Argument 4 — The FII underweight is at 9-year deep. The FII underweight in FMCG is at 220 bps vs. MSCI India weight, the deepest in 9 years. A reversal of this underweight would imply ~$2.4 billion of incremental FII flow over 12-18 months, a meaningful demand catalyst.

Argument 5 — The macro setting is the most supportive in 3 years. RBI rate cuts (-125 bps in CY26 YTD, further -50 bps expected), normal monsoon forecast (96% of LPA), government support (MGNREGA wage hike, PM-KISAN instalment, free foodgrain extension), and the GST 2.0 anniversary base all align favourably.

The conditions to the Overweight call are:

• Volume growth in Q1 FY27 must be >6% YoY (the Nifty FMCG data is due mid-July 2026)
• The monsoon must deliver >90% of LPA (the IMD forecast is 96% with a 5% error band)
• Input costs must not spike back to FY24 peaks (the 12-month futures curve is in our favour, but the risk is real)
• No major regulatory reversal (the GST 2.0 framework must hold)

If any one of these conditions fails materially, the call would be downgraded to Neutral. If two or more fail, the call would be downgraded to Underweight.

11.2 Top 3 picks — ITC, HUL, Tata Consumer

Pick 1 — ITC Ltd (Target: ₹340-360, 12-month view, +19-26% upside)

ITC is the highest-conviction pick in the FMCG universe for FY27. The investment case rests on 5 pillars:

• Cigarette pricing power — 4-6% MRP-led growth with volume decline of 1-2% means a net 2-4% revenue growth, with segment EBITDA margin at 55%
• FMCG-Others inflection — the segment is now at 6.8% EBITDA margin (vs. 2.8% in FY20) and the path to 10% by FY28 is visible
• Hotels demerger upside — the demerged entity is benefiting from the post-COVID leisure and business travel cycle
• Valuation discount — 17.1x P/E vs. 5Y average 20.4x (-16.2%), the second-largest discount in the universe
• Dividend yield of 5.09% — the highest in the Nifty FMCG universe, providing a strong total return component

The risks are (1) the cigarette volume contraction at 2-3% per year, (2) the FMCG-Others execution risk to the 10% segment EBITDA margin target, and (3) the ESG/governance risk on capital allocation and related-party transactions. The risks are well-known and well-priced.

Pick 2 — Hindustan Unilever (Target: ₹2,400-2,500, 12-month view, +12-17% upside)

HUL is the highest-quality compounder in the Nifty FMCG universe, with the most premiumisation runway, the best distribution moat, and the largest addressable categories. The investment case rests on 5 pillars:

• Volume re-acceleration to 5-7% in FY27 (from 1-3% in FY24-FY25)
• Premium portfolio to cross 38% of revenue (from 32% in FY26) by FY28
• New categories (Wellbeing Nutrition, OZiva, incubated D2C) to be 4-5% of revenue
• Valuation discount — 33.5x P/E vs. 5Y average 38.4x (-12.8%)
• Operating leverage on volume — each 100 bps of volume growth = 40-50 bps of EBITDA margin expansion

The risks are (1) the rural recovery delay, (2) the D2C disruption in personal care, and (3) the parent capital allocation dynamics (Unilever plc's global strategy). The risks are diversifiable through the diversified portfolio.

Pick 3 — Tata Consumer Products (Target: ₹1,250-1,350, 12-month view, +13-22% upside)

Tata Consumer is the highest-growth pick in the universe, with the most credible M&A pipeline and the strongest international turnaround story. The investment case rests on 5 pillars:

• M&A-led growth — Capital Foods, Organic India, Stellar Health (Soulfull), and the Tata group's recent Haldiram's stake
• Volume re-acceleration in salt (Tata Salt), tea (Tata Tea), and coffee (Tata Coffee, Eight O'Clock)
• Premium portfolio (Tata Tea Gold, Tata Salt Plus, Tata Sampann premium) growing at 12-15% YoY
• International turnaround — Eight O'Clock US and Tata Tea UK recovering
• Operating leverage on the M&A portfolio — acquired businesses are sub-scale at the EBITDA line

The risks are (1) M&A integration risk, (2) international tea and coffee commodity exposure, and (3) the salt regulatory risk. The risks are higher than ITC and HUL, but the upside is also higher.

11.3 Top 3 avoids — Emami, Dabur, Marico

Avoid 1 — Emami (Underperform, 12-month view, -10% to flat return)

Emami is the most challenged name in the universe. The Kesh King underperformance (acquired for ₹1,650 cr in 2015, still sub-scale) is a structural drag, the distribution slippage in modern trade and quick commerce is a secular headwind, and the turnaround thesis is not yet visible in the Q4 FY26 print. The A&P intensity of 16.4% of sales is 2x the universe average and is not generating commensurate volume response. The stock at 21.8x P/E is at a -36% discount to its 5Y average, but the discount is justified by the structural challenges.

Avoid 2 — Dabur India (Underperform, 12-month view, flat to +5% return)

Dabur is facing secular D2C disruption in the hair care, oral care, and personal care categories. The hair oils, chyawanprash, and juices categories are all seeing the impact of mamaearth, WOW, Dabur Red, and other D2C brands. The A&P intensity of 9.4% of sales is rising without commensurate volume response. The international FX exposure (MENA, Africa) is a drag. The stock at 39.7x P/E is at a -17% discount to its 5Y average, but the discount is warranted.

Avoid 3 — Marico (Underperform, 12-month view, flat to +6% return)

Marico is in the middle of a structural transition from a coconut oil business to a foods + international business, and the transition is not yet delivering on margin or growth. The foods business (acquired True Elements, Z Pure, planned Sanand plant) is sub-scale and unprofitable, the Bangladesh macro stress is a drag, and the copra price volatility is a risk. The stock at 60.4x P/E is at a +11% premium to its 5Y average, the only "premium" name in the universe (along with Tata Consumer and Colgate) and the premium is not justified by the fundamentals.

11.4 Five things to watch

1. NielsenIQ India FMCG volume growth (Q1 FY27 print, mid-July 2026). This is the single most important data point for the sector. The Q3-Q4 FY26 prints were the inflection; the Q1 FY27 print is the sustainability test. A print of >7% YoY would be a decisive bullish signal; a print of <3% would be a decisive bearish signal.

2. The southwest monsoon (Jun-Sep 2026, weekly updates from IMD). The IMD's first stage forecast is 96% of LPA, the second stage is 97% of LPA. The actual delivery is the critical variable. A cumulative rainfall of 95%+ of LPA would be supportive; a cumulative of <90% would be a major negative for the rural recovery thesis.

3. FII flow into Indian FMCG (daily, NSDL data). The FII underweight of 220 bps is at a 9-year deep. Any net buying of >₹500 cr/week in the Nifty FMCG index would be a structural shift and a re-rating catalyst. The current rate is mildly positive (+₹200-300 cr/week) but the trend needs to continue and accelerate.

4. ITC FMCG-Others EBITDA margin (quarterly, in ITC's segment reporting). The segment has been sub-scale and unprofitable for a decade, and the Q3-Q4 FY26 prints of 6.8% segment EBITDA margin are the first time the segment has been at this level. The path to 8-10% segment EBITDA margin by FY28 is the central re-rating catalyst for ITC. The Q1 FY27 print will be the next critical data point.

5. Nestle India Maggi Ketchup and chocolate portfolio scaling (quarterly, in Nestle's investor disclosures). Maggi Ketchup is at ~₹500 cr revenue and growing 35%+. The chocolate portfolio crossed ₹1,000 cr annualised in FY26 and is the next growth lever for Nestle. The scaling of these two adjacencies to Maggi noodles is the central driver of the Nestle India re-rating thesis beyond the volume re-acceleration in the core Maggi portfolio.

11.5 The 5-year view

A 5-year view of the Nifty FMCG universe is decidedly constructive. The sector should deliver:

• ~10-12% revenue CAGR for the universe, driven by India nominal GDP growth, FMCG TAM expansion (8-10% CAGR), and selective M&A
• ~12-14% PAT CAGR, supported by margin expansion (50-80 bps over 5 years from premiumisation and operating leverage)
• Multiple expansion of 10-20% from the current 41.2x P/E to 45-50x P/E (back to the 5-year mean and beyond)
• Total return of 14-18% CAGR over 5 years

The 5-year total return is comparable to the Nifty 50's expected 13-16% CAGR but with lower volatility and higher dividend yield. For investors with a 5+ year horizon and a preference for quality, dividends, and lower drawdowns, the Nifty FMCG index is one of the most attractive long-term compounding vehicles in the Indian market.

11.6 Closing view

The Indian FMCG sector is at an inflection point. The three-year cycle of de-rating, low volume growth, and margin compression is ending. The FY27 setup — rural recovery, GST 2.0 anniversary base, input cost tailwind, monetary easing, and the FII underweight reversal — is the most favourable in five years. The valuation discount to 5-year average of 8-17% across metrics is the structural entry point. The management commentary across the universe has shifted from cautious to cautiously optimistic.

The risks are real — monsoon variability, input cost spikes, D2C disruption, regulatory tightening, and FII flow reversal. But the risk-reward is decisively in favour of the bulls, with an expected value of +13% to +17% return for the Nifty FMCG index over the next 12-18 months in a probability-weighted base case.

The volume comeback is the story. The pricing power names will be the winners. The rural recovery will be the catalyst. FY27 is the year.

The Nifty FMCG sector is rated Overweight.